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                                                            Zusammenfassung                                               
 
 
        Eine große Anzahl von Ionenkanälen und Transportern tragen zur Regulation der 
elektrischen Aktivität in pankreatischen B-Zellen bei. Die Aktivitäten dieser Kanäle kontrollieren 
die Ionentransportation, entscheiden sich das Membranpotential und regulieren die Sekretion des 
Insulins und das Überleben der Zellen.   
        Die Hormone und die Peptide sind wichtige Regulatoren in den Kanalaktivitäten in den 
Insel-Zellen. In diesem Studium, demonstrieren wir, dass das Leptin (100 nM), der IGF-1 (50 
ng/ml) und das Adrenaline (1 µM) den auswärts Strom anregen und die Zellmembranen 
hyperpolarizieren. Dadurch hemmt es die Sekretion des Insulins in den Mäuseinsel-Zellen. Die 
Anwendungen von den Hemmer der PI3-kinase wie LY294002 und Wortmannin kehren die 
Wirkung der Hyperpolarization um. Es deutet darauf hin, dass die hemmende Wirkungen der 
Insulinsekretion vom Leptin, IGF-1 und Adrenaline durch PI3-Kinase Signaling Pathway sind. 
Das exogene Insulin (1 µM) dagegen hat keinen Einfluss an der Kanalaktivität. 
        Das Amyloid-Peptid ist bekannt in vielen verschiedenen Zellen, die Apoptose zu 
stimulieren. Die apoptotische Wirkung vermittelt zum Teil durch die Bildung des Ceramids. Das 
Amyloid beeinflusst besonders mit dem Überleben der pankreatischen B-Zellen. Dieses Studium 
zeigt, dass das Amyloid und das Ceramid auf die Aktivitäten der Ionkanäle wirkt und das 
Amyloid auf die Bildung des Ceramids wirkt.  
        Die Mäuseinsel-Zellen werden isoliert und mit Amyloid Aβ1-42 (1-10 µM) oder C2-ceramid 
(20-60 µM) 1-2 Tagen behandelt. Die Färbung vom TUNEL zeigt, dass das Amyloid und C2 die 
Apoptose der Insel-Zellen signifikant stimuliert. Die Patch-Clamp-Experimente zufolge werde 
die Anwendung vom Islet-associated-Polypeptid (IAPP) 5 µM innen 15 Min. den Strom von den 
KV-Kanäle der Whole-Zelle deutlich verringert. Die Wirkung des Amyloids werde vom C2 20 
µM nachgemacht, hingegen das inactive Di-C2 (20 µM) keine deutlichen Wirkung auf dem 
auswärts Strom in den Insel-Zellen hat. Laut die Färbung der Immunofluorezenz für das Ceramid, 
das Amyloid Aβ1-42  vermehrt die Bildung des Ceramids. Die Einführung von der Apoptose und 
der Verringerung des Strom von den KV-Kanäle bei dem Amyloid werde in acid-
Sphingomyelinase-Knockout (ASM-KO) Insel-Zellen aufgehoben. Schließlich, das Amyloid 
führt die Insel-Zellen zu der Apoptose. Der Effekt ist vermutlich durch die Aktivität von der 
ASMase, die sich die vermehrten Bildung des Ceramids und die Hemmung der Aktivität der 
Ionkanäle ergibt. 
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                                                                  SUMMARY 
 
 
        A large number of ion channels and transporters contribute to regulation of electrical 
excitability in pancreatic beta cells. Activities of these ion channels control transportation of ions 
and determine the membrane  potential, eventually regulate insulin secretion and cell survive.  
        Hormones and peptides are very important regulators in channel activities in insulin 
secreting cells. In this study we demonstrated, leptin (100 nM), IGF-1(50 ng/ml) and adrenaline 
(1 µM) induce outward current and hyperpolarization in cell membrane which result in inhibition 
of insulin secretion in mouse islet cells. Application of PI 3-kinase inhibitors like LY294002 
and/or wortmannin reverse the hyperpolarization-induced effect by these hormones. It indicates, 
the effect of leptin, IGF-1and adrenaline act as inhibitors of insulin secretion through PI 3-kinase 
signaling pathway. In the contrast, exogenous insulin (1 µM) failed to affect channel activity 
under the same condition like leptin, IGF-1 and adrenaline.  
        Amyloid peptides are known to stimulate apoptosis in a wide variety of cells, an effect 
partially mediated by formation of ceramide. Specifically, amyloid is known to interfere with 
survival of pancreatic beta cells. As in some cells apoptotic death is paralleled by ceramide 
dependent alterations of plasma membrane ion channel activity, the present study elucidated the 
effects of amyloid on ceramide formation and ion channel activity in mouse islets. Mouse islet 
cells were isolated and treated in cell culture with amyloid peptide Aß1-42 at concentrations 
between 1 and 10 µM or C2 ceramide (20-60 µM) for 1 – 2 days. As disclosed by TUNEL 
staining, both, amyloid peptide and C2-ceramide, significantly stimulated apoptotic death of 
pancreatic islet cells. According to patch clamp experiments, administration of islet associated 
polypeptide amyloid IAPP (5 µM) within 15 minutes significantly decreased outwardly rectifying 
whole cell current. The effect of amyloid was mimicked by N-acetyl-D-sphingosine (C2-
ceramide, 20 µM), whereas inactive di-ceramide (20 µM) did not significantly modify islet cell 
outward currents. According to immune fluorescent staining for ceramide, amyloid peptide Aß1-42 
increased ceramide formation. Induction of apoptosis and decrease of KV channel current by 
amyloid was abolished in islet cells from mice deficient in acid sphingomyelinase. In conclusion, 
amyloid induces apoptotic islet cell death presumably through activation of acid 
sphingomyelinase that results in elevated production of ceramide and subsequent inhibition of ion 
channel activity.  
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1.    INTRODUCTION 
 
1.1    Ion channels and insulin secreting cells  
         Ion channels are an integral membrane protein or an assembly of several proteins. They 
facilitate the diffusion of ions across biological membranes through their electrochemical 
gradient. The conformational change between closed and open state (see Fig. 1.) is called gating. 
 
 
closed 
conformation 
change 
open 
 
 
Fig. 1. Channels cycle between open & closed conformations 
 
        According to the modulator in gating activity of ion channels, they can be classified to 
different groups :  
  - ligand gated channels that are regulated by neurotransmitters  
- voltage gated channels that are regulated by the transmembrane potential (electric field)  
- second messenger gated channels that are regulated by nucleotides directly or through G-
proteins  
- mechanosensitive channels that are regulated by osmotic pressure, membrane curvature or 
sharing forces 
- gap junctions or porins are not gated  
        Ion channels can also be classified according to their ion selectivity : 
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- K+ channels 
- Na+ channels 
- Ca2+ channels 
- Cl- channels 
- non-selective cation channels   
 
        Ion channels function as electrical signal transducers and they control the electrical 
properties of all living cells. They also take the responsibility for the regulation of the volume of 
the cell and participate in intracellular signalling. The physiological process of the nerve impulse 
is generated by channels mediating the conduction across the synapses, and channels are 
especially prominent components of the nervous system. In addition, ion channels participate in a 
wide variety of biological processes that involve rapid changes in cells, such as cardiac, skeletal, 
and smooth muscle contraction, epithelial transport of nutrients and ions, T-cell activation and 
pancreatic beta-cell insulin release.  
        Pancreatic islet cells are endodermally-derived specialized excitable cells that possess many 
properties of neurons. A large number of ion channels, pumps, and transporters contribute to the 
regulation of electrical excitability in pancreatic beta-cell. They are responsible for the resting 
membrane potential (Vm) of the beta cell of about -60 mV when extracellular glucose 
concentration is lower than 5.6 mM (see Fig. 2.). 
         
 
Fig. 2. Beta cell ion channels (from Aschcroft, et al. 1989). 
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1.2.  KATP channel   
  
        In 1968, Dean and Mathews proved for the first time that beta-cells are electrically excitable 
and that glucose controlled this electrical activity  using intracellular micro-electrode recording 
techniques (Dean,et al.1968; Dean,et al.1970).  Later on, the development of patch clamp 
techniques helped to elucidated the key role of ATP-sensitive potassium (KATP) channels in the 
resting membrane potential of the beta-cell as well as the importance of these channels in insulin 
secretion. Experiments indicated that the initial depolarization induced by glucose is caused by a 
decrease in the resting membrane permeability to potassium. Thus, the K+ permeability of the 
beta cells is a critical determination of glucose-induced insulin release. The experiments have 
first  identified a potassium channel (K+-channel) that is active at the resting potential and is 
inhibited by glucose. Closure of this channel requires glucose metabolism (Ashcroft,et al.1984; 
Cook,et al.1984). 
 
1.2.1    Structure of KATP channel 
 
          These potassium channels belong to the inward rectifier (Kir) subfamily. The name of Kir  
came from the fact that these channels conduct K+ current into the cell more easily than to the 
outside of the cell. Using Kir3.1 cDNA as a probe, Kir6.1 as a novel Kir member was identified  
from a rat islet cDNA library (Cook,et al.1984). Northern blot analysis showed that Kir6.2 
mRNA is expressed at very high levels in pancreatic islets and in insulin secreting cells MIN6 
and HIT-cells and is expressed relative lower in other organs which are known to have KATP 
channels, like skeletal muscle, heart and brain. However, expression of mouse Kir6.2 alone in 
COS-1 cells, HEK239 cells or Xenopus leavis oocytes did not induce any significant current, 
indicating that Kir6.2 alone does not function as a KATP channel (Inagaki,et al.1995). 
        Functional KATP channels are only formed when  Kir6·2 is expressed together with 
sulfonylurea receptor 1 (SUR1) . The SUR1 is a regulatory protein channel that was finally 
cloned after numerous experiments using the partial peptide sequences only in 1995 (Inagaki,et 
al.1995). Sulfonylurea, however, such as Tolbutamide, glyburide are used in the treatment of type 
2 diabetes since more than 50 years. This 1582 amino acid protein SUR1  is expressed at high 
levels in pancreatic islets and pancreatic beta cell lines including MIN6, RINm5F and HIT 
(Inagaki et al.1995). The SUR1 is a member of the ATP binding cassette (ABC) family of 
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membrane proteins, which includes the cystic fibrosis transmembrane conductance regulator 
(CFTR) chloride channel among others (Higgins.1992; Aguilar-Bryan et al.1999). The Kir6.2-
SUR1 complex forms the functional KATP channel. The complete channel consists of a core of 
four Kir 6.2 subunits surrounded by four SUR1 subunits (Inagaki et al.1995; Sakura et al.1995).  
The SUR1 complex acts as a regulator of the K+ channel, binding ATP as well as sulfonylurea 
compounds.  Both ATP and tolbutamide have inhibitory actions on the KATP channel and 
therefore inhibit K+ efflux (see Fig. 3).  Each  Kir channel subunit folds into the membrane to 
form two transmembrane domains (M1 and M2) surrounding a pore loop (P). The transectional 
model shows Kir6.2 subunits surrounded by their accompanying SUR1 subunit (see Fig. 4.).  
 
 
 
 
Fig.3. The Kir6.2-SUR1 complex (from Miki, et al. 1999). 
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Fig.4.  Transection of Kir channels: The structure reveals that Kir channels consist of four 
subunits: each subunit folds into the membrane to form two transmembrane domains (M1 and 
M2) surrounding a pore loop. The four pore loops line the central ion-conducting pore with the 
M1 and M2 subunits (from Miki, et al. 1999). 
 
        The isoforms of SUR have been cloned, SUR1, SUR2A and SUR2B. SUR2A, a divergent 
from of SUR2 but highly homologous to SUR1 was found in 1996 (Isomoto et al. 1996) . This  
subunit is a component of the smooth muscle KATP channel, which the heart KATP channel is 
composed of Kir6·1 and SUR2B. The tissue and  cells distribution of SUR1, SUR2A, Kir6·1 and 
Kir6·2 assessed by Northern blot analysis is summarized in Table 1(Chutkow et al.1996; Yamada 
et al.1997). 
 
Table 1.  Tissue distribution of KATP channel subunits. The levels of expression represent the 
relative abundance of mRNA of each subunit among different tissues (from Miki, et al. 1999). 
 
 
 
 
1.2.2    Function of KATP channel 
        KATP channels play a regulatory role in many cellular functions such as hormone secretion, 
excitability of neurons and muscles and cytoprotection in heart and brain ischemia, by coupling 
the cell metabolism to electrical activity (Ashcroft.1998c; Terzic et al.1995). Since the primary 
function of insulin secreting cell is secretion of insulin, the KATP channels in pancreatic beta-cells 
are critical in the regulation of glucose-induced and sulfonylurea-induced insulin secretion. That 
glucose-induced insulin secretion is dependent on the closure of the KATP channels has in 
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principle become accepted (Cook et al.1998). 
         Elevation of plasma glucose concentration to more than 8  mM results in the depolarization 
of the  beta cell. Glucose is taken up into the beta-cell by the glucose transporter GLUT2 and is 
metabolized through glycolytic pathways and oxidized in the mitochondria yielding in the 
generation of ATP. An increase in the ATP/ADP ratio causes closure of the KATP channels and 
depolarization of the cell via the decreased K+ permeability (Rorsman et al.1985) (see Fig.5). 
Under resting conditions, KATP channels are open due to the interaction of ADP with SUR1.  
 
      
                                   
 
Fig. 5.  KATP channel plays a crucial role in glucose-induced and sulfonylurea-induced 
insulin secretion.(GLUT2, glucose transporter 2; VDCC, voltage-dependent calcium channel; 
SU, sulfonylurea; Ψ, membrane depolarization.) (from Miki, et al. 1999) 
 
        Mutations in either the Kir or SUR1 can result in KATP channel defects. It has been found 
that Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI), also referred to as familial 
hyperinsulinism or pancreatic nesidioblastosis, a rare disease is caused by mutations of SUR1 and 
Kir6.2 that result in constitutionally closed channels (Huopio.2002). This disease is characterized 
by inappropriate  high levels of insulin secretion despite severe hypoglycemia.  
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1.2.3  The regulation of the KATP channel 
 
        Several ligands affect KATP channel activity. Both ATP (with or without Mg2+) and 
tolbutamide have inhibitory effects on the KATP channel and inhibit K+ efflux. This leads to 
depolarization of the pancreatic beta-cell, stimulation of Ca2+ influx and insulin secretion. ADP 
and pharmacological K+ channel openers, such as diazoxide, stimulate the KATP channels and 
promote  K+ efflux, that result in membrane repolarization and inhibition of insulin secretion (see 
Fig. 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.  Regulators of KATP channel: ATP inhibits, and PIP2 activates, by direct interaction with 
Kir6.2 subunits. Sulphonylureas inhibit, and diazoxide activates, by interaction with the SUR 
subunit. In addition, in the presence of Mg2+ and ADP can activate the channel through 
interaction with the NBFs of SUR.  
 
1.2.3.1    ATP and ADP 
 
        It is well accepted, KATP  channels are controlled by intracellular ATP and ADP 
concentrations or the ATP/ADP ratio (Ashcroft et al.1990; Seino et al.2000). ATP inhibits KATP 
Mg ADPMg ATP
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channels, while ADP opens them. Single channel recording of KATP channel activity using the 
patch clamp method showed that channel open in an ATP-free solution and close by brief 
application of MgATP at millimolar concentrations (Cook.1984; Noma.1983; Trube et al.1984).  
        Although Kir6.2 contains no obvious consensus sequences for nucleotide binding, a single 
mutation in this subunit (K185Q) dramatically reduces the ability of ATP to inhibit channel 
activity (Tucker et al.1997). This observation demonstrats that ATP inhibits KATP channels by 
binding to Kir6.2 . 
        Application of non-hydrolysable analogues of ATP, and of ATP in the absence of Mg2+ still 
resulted in inhibition of channel activity (Ashcroft et al.1989b).  It suggests that ATP hydrolysis 
is not necessary for channel inhibition and that binding of the molecule is sufficient to induce 
KATP channel closure. 
        The comparison of ATP, GTP and ITP revealed that only ATP causes high affinity channel 
inhibition (Tucker et al.1998) . It suggests that elements unique to the adenine ring are critical for 
the specificity of nucleotide binding and/or for the ability of nucleotide binding to induce the 
channel closure. The ability of ATP and ADP, but not AMP, to inhibit the channel suggests that 
more than the a-phosphate of the nucleotide is required for the interaction (Tucker et al.1998).  
 
1.2.3.2    Sulfonylurea compounds   
 
        KATP channels are targets of anti-hyperglycemic compounds. The best-known drugs that 
regulate KATP channels are the sulfonylureas. Sulfonylureas are widely used to treat type 2 
diabetes mellitus in humans, acting as insulin secretagogues by binding to SUR1, blocking 
pancreatic beta-cell KATP channel  and triggering insulin release (Proks et al.2002). 
        Distinct sulfonylureas have different binding affinities for SUR subtypes. Some of them are 
very specific for SUR1 (e.g. nateglinide, mitiglinide), some are moderately specific for SUR1 
(e.g. glyburide, glimepiride), and others are essentially not selective (e.g. repaglinide) (Quast et 
al.2004). 
        The mechanism of Sulfonylurea by which they induce the closure of KATP channels is best 
explained by a two-site model. In the absence of nucleotide, the dose-response for tolbutamide to 
block KATP currents shows both a high-affinity (Ki = 2.0 microM) and a low-affinity (Ki = 1.8 
mM) binding site (Gribble et al.1997).  It has also been demonstrated that the high-affinity site 
resides on SUR1, whereas the low-affinity site is located on Kir6.2.  Because the concentrations 
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required to inhibit the Kir6.2 subunit are much higher than those found in the plasma of patients 
treated with the drugs, it is suggested that the low-affinity site has no clinical relevance (Ribalet 
et al.1996). Binding of sulfonylureas to the cytoplasmic domains of SUR1 ultimately results in 
closure of the pore formed by Kir6.2. There must be a close physical association between the 
sulfonylurea binding site on SUR and the Kir6.2 subunit (Aguilar-Bryan et al.1999). The exact 
transduction process is still unclear. 
 
 
1.2.3.3    Diazoxide and other channel openers 
 
         A diverse group of compounds, referred to as potassium channel openers (KCOs) are able 
to open KATP channels and thus hyperpolarize the cells. Diazoxide, pinacidil, nicorandil, 
cromakalim and RP-49356 belong to this group of drugs. 
         It has been shown that inhibition of the KATP-mediated current by an initial application of 
100 mM ATP was partly reversed by the addition of 100 mM diazoxide (Ashcroft et al.1989a and 
b). The target binding site of potassium channel openers is proposed to be the sulfonylurea 
receptor, based on observations that the response of reconstituted KATP channels to either 
diazoxide, cromakalim, or pinacidil correlates with the SUR subtype (Inagaki et al.1996; Isomoto 
et al.1996). Diazoxide does not competitively displace glibenclamide at the KATP channel, 
suggesting that it has a other binding site on the channel than the sulfonylureas (Panten et 
al.1989). 
         The study about  KCOs demonstrated that treatment with KCO compounds can indeed lead 
to inhibition of insulin secretion and metabolic "rest" of beta-cells. Eventually KCOs preserve the  
beta-cell function by reducting  insulin secretion in a rat diabetes model (Kresten et al.2004). 
          Except being used for the treatment of hyperinsulinemic states or as smooth muscle 
relaxants reducing hypertension, channel openers also have been tested in asthma and 
cardiovascular disease. Intracerebroventricular administration of K+ channel "openers" block 
experimentally induced seizures in rodents through the hyperpolarization of neurons. K+ channel 
openers may also be useful in the treatment of neurodegenerative diseases, pain and cerebral 
ischemia (Gehlert et al.1994). 
 
 
 14 
1.2.3.4    Phosphatidylinositol bisphosphate (PIP2)   
 
          Phosphatidylinositol phosphates have been found to affect ion channel activity. Exposure 
of KATP channels to 5 µM Phosphatidylinositol bisphosphate (PIP2) reduces the inhibitory effect 
of ATP and blocked the activation of channel by diazoxide. Prolonged application of 10 µM PIP2 
completely removes inhibition of KATP channels by 1 mM ATP (Baukrowitz et al.1998). Similar 
to PIP2, phosphatidylinositol-4-phosphate (PIP)  is also able to reduce the inhibitory effect of 
ATP. Whereas phosphatidylinositol (PI) has no obvious effect on KATP channels even at a 
10 times higher concentration (Baukrowitz et al.1998). PIP2 also reduces the maximal block 
produced by saturating concentrations of tolbutamide (Koster et al.1999) and glibenclamide 
(Krauter et al.2001). 
        The mechanism by which PIP2 and PIP open KATP channels involves an action on the Kir6.2 
subunit and a shift in ATP sensitivity. PIP2 incorporates into the cell membrane and interacts with 
the carboxyl terminus of the KATP channel. This interaction distorts the ATP-binding site and 
prevents ATP from binding. In the absence of  PIP2 the channel is able to bind ATP, that causes 
the channel to close (Frances et al.1998). PIP2  therefore stabilizes a state in which the channel 
can not interact with ATP (Alexey et al.1998). 
 
  
1.2.3.5    Regulation by other factors 
 
         Experiments without nucleotides ATP/ADP indicate that guanosine-5'-triphosphate (GTP)  
(10 microM to 1 mM) and guanosine diphosphate (GDP) (100 microM to 1 mM) evoke dose-
dependent KATP channels activation in RINm5F-cells (Dunne et al.1986; Findlay.1987).  
         Cations and anions also influence the open probability of the KATP channel. It has been 
shown that 5 mM free Mg2+ is required to produce 50% inhibition of KATP channel activity in rat 
pancreatic beta-cells and millimolar concentrations of divalent cations produce an inhibition in 
channel activity (Ashcrof et al.1989b). Other experiments suggest that the open probability of the 
channel is increased 2- to 10-fold when C1- is substituted by glutamate or aspartate (Tabcharani 
et al.1989). The effects of cytoplasmic pH on the KATP channel appear to interact with those of 
ATP (Misler et al.1989). In the presence of ATP, channel activity increases when the intracellular 
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pH (pHi ) is enhanced to 7.9 and decreases when pH is reduced to 6.3 in inside-out patches from 
rat beta-cells. However, changes of pHi in ATP-free solution have little effect on channel activity 
(Misler et al.1989).  
         At physiological concentrations, nicotinamide adenine dinucleotide (NAD) and 
nicotinamide adenine dinucleotide phosphate (NADP) inhibit Kir6.2/SUR1 currents through the 
interaction with the nucleotide inhibitory site of Kir6.2. This inhibition is dependent on the 
presence of SUR1, which may act by increasing the width of the nucleotide-binding pocket of 
Kir6.2 (Dabrowski et al.2003). They may therefore contribute to the resting level of channel 
inhibition in the intact cell.  
 
 
1.3    Voltage-dependent K+  (Kv)  channel 
 
         Voltage-dependent or voltage-gated K+ channels (Kv channels) are present in all animal 
cells. They open and close upon changes in the transmembrane potential. Kv channels are one of 
the key components in generation and propagation of electrical impulses in the nervous system 
and heart. In the pancreas during the physiological process of insulin secretion, increased glucose 
metabolism depolarises beta-cells by closing KATP channels. This triggers action potential due to 
the opening of voltage-dependent Ca2+ channels. Repolarisation of pancreatic beta-cell is 
mediated by the activation of  Kv channels. 
 
 
1.3.1    Structure of Kv channel in beta cell 
 
         The tetrameric structure of Kv channels is made of two functionally and structurally 
independent domains: an ion conduction pore and voltage-sensor domains. The ion conduction 
pore is made of four α-subunits which are arranged symmetrically around the conduction 
pathway. Voltage-sensor domains are positioned at the periphery of the channel and consist of 
four transmembrane segments (S1-S4) (Vanessa et al.2003) (see Fig. 7). The pore-forming α-
subunits and modulatory β-subunits exist in the membrane as one component of macromolecular 
complexes, able to integrate a myriad of cellular signals that regulate ion channel behavior 
(Torres et al.2007). In response to the membrane potential, the voltage-sensor domains 
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structurally rearrange, particularly S4, which includes positively charged amino acids at every 
third position, leads to conformational changes in the conduction pore, which opens or blocks the 
ion conduction pathway (Fatemeh et al.2006). 
 
 
  
 
 
Fig. 7. Architecture of a voltage-dependent K+ channel:  Transmembrane-spanning segments 
(S1–S6) are labelled (dark segments); S1–S4 form the voltage sensor and S5–S6 form the pore. 
Four subunits surround the pore (Ruta, et al. 2003). 
 
 
        Numerous studies have been carried out to detect subunits of Kv channels (MacDonald et 
al.2001and2002; Ling et al.2004). Using reverse transcriptase-polymerase chain reaction (RT-
PCR) identification of mRNA transcripts and using Western blot and immuno-histochemical 
studies to detect relevant subunits expressed abundantly at the protein level, a large number of Kv 
channel subunits have been detected in insulin secreting cells (MacDonald et al.2003b).      
         The first report of Kv2.1 expression in an insulin-secreting cell (βTC-neo) was detected by 
RT-PCR method (Roe et al.1996a).  Later afterwards using a dominant-negative strategy, 
MacDonald and his colleagues demonstrated that Kv2.1 contributes 60 to 70% of the voltage-
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dependent outward K+ current in rat beta-cells and HIT-T15 insulinoma cells . They also proved 
that Kv channels regulate glucose-induced insulin secretion in rat islets (MacDonald et al.2001). 
The experiments established that Kv2.1 mediates the majority of the voltage-dependent outward 
K+ current in rat and mouse beta-cells (MacDonald et al.2001; Tamarina et al.2005). 
          Kv currents resistant to tetraethylammonium (TEA) but blockable by 4-aminopyridine (4-
AP) were recorded from mouse pancreatic islet cells. These channels are opened at voltages more 
positive than -40 mV, display a rapid turn on and inactivate completely within 250 ms (Findlay et 
al. 1985; Smith et al.1989). Expression of  Kv1.4, Kv1.5, Kv2.1, Kv2.2, Kv3.1 and Kv3.2 were 
detected in INS-1 cells whereas other Kv channels, Kv1.1, Kv1.2, Kv1.3, Kv1.6 and Kv3.4 were 
not detected (Su et al. 2001). So far, there are at least 11 mammalian Kv channel families and 
various related families (EAG related, KCNQ or KvLQT and KCa) (see Table 2) (Yasuda et al. 
2008; Ullrich et al. 2005; MacDonald et al.2003b; Sano et al.2002; Christie MJ.1995;  Dilks et 
al.1999; Hugnot et al.1996; Ottschytsch et al.2002; Salinas et al.1997; Stocker et al.1998; Bauer 
et al.2001; Robbins.2001). Among these channel families, members of the Kv1, Kv2, and Kv3 
channel families regulate currents have been observed in pancreatic beta-cells (Dukes et al.1996; 
Xu et al.1995; Blaine et al. 1998; Koch et al. 1997). 
 
Tab.2. Family members and current types of mammalian Kv channel (from MacDonald et 
al.2003b). 
 
                                                      
 
1.3.2    Function of Kv channel in insulin-secreting cells 
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        Many Kv channel genes, represented by more than 40 mammalian isoforms (termed Kv1 to 
Kv9) (Coetzee et al.1999), give rise to overlapping functions, primarily regulating repolarization 
of the plasma membrane. Experiments involving inhibition of Kv channels have shown that Kv 
channels play an important role in regulating beta-cell calcium oscillations in response to glucose 
stimulation. In pancreatic beta cells, Kv channels are potential mediators of repolarization, closure 
of Ca2+ channels, and limitation of insulin secretion (Ullrich et al. 2005b). 
         In rat islets and insulinoma cells, inhibition of  Kv1.4, 1.6, and 2.1 channels with 
tetraethylammonium (TEA) enhances glucose-induced insulin secretion by 2- to 4-fold 
(MacDonald et al.2001; Su et al. 2001; Ullrich et al. 2007).   
         Studies in 1977-1980 have observed  that the general antagonist of Kv and Ca2+-activated 
K(KCa) channel TEA prolongs mouse beta-cell action potentials. These are the earliest studies  
showing that repolarising outward K+ currents modify insulin secretion and that inhibition of the 
channels enhances insulin secretion from rat islets (Atwater et al.1979; Henquin.1977; Henquin 
et al.1979; Herchuelz et al.1980). Later afterwards, numerous experiments have demonstrated the 
stimulatory effect of TEA on insulin secretion (MacDonald et al.2001; Henquin.1990; Philipson 
et al.1994; Eberhardson et al.1996; Roe et al.1996a; Gopel et al.1999). Mutations in Kv and 
related channels are known to play important roles in disorders such as familial long Q-T 
syndrome, episodic ataxia type 1, benign familial neonatal convulsion, familial and thyrotoxic 
hypokalemic periodic paralysis, and autosomal dominant deafness (Hatta et al.2000). Genes 
encoding both Kv1.7 and Kv3.3 have been mapped to a region of chromosome 19 (19q13.3–13.4) 
containing a diabetes susceptibility locus (Kalman et al.1998). Polymorphism of Kv channels or 
their numerous regulatory proteins could lead to loss or gain of function. Increased Kv channel 
function would shorten glucose-stimulated insulin secretion by causing premature repolarisation 
of the action potential and decreased Kv channel function could lead to beta cell over-excitability 
and increased cytosolic Ca2+, possibly leading to apoptosis through activation of the caspase 
cascade and induce of oligonucleosomal DNA fragmentation (Chandra et al.2001). Other 
experiments show that Kv1.3 -/- mice have an increased basal metabolic rate and are resistant to 
the development of obesity in response to a high fat diet (Xu et al.2003).  
 
 
1.3.3    Modulation of Kv 
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1.3.3.1    Syntaxin 
 
         Research in brain synaptosomes has shown the physical and functional interactions between 
syntaxin 1A and Kv channels. Kv channels may play a role in synaptic efficacy and neuronal 
excitability. Particularly, syntaxin 1A was found to associate with Kv1.1 and Syntaxin affected 
the channel amplitude. At low syntaxin concentrations there was a significant increase in 
amplitudes, and at higher concentrations, however, the amplitudes decreased, probably because 
of a concomitant decrease in cell-surface channel expression (Fili et al.2001). Additionally, it has 
been demonstrated that the activity of the delayed-rectifier K(+) channels (K(DR)) channel 
subtype, Kv1.1, identified by its specific blocker dendrodotoxin-K, is inhibited by SNAP-25 
(synaptosome-associated protein of 25 kDa) in insulinoma HIT-T15 beta cells (Ji et al.2002). A 
co-precipitation study of rat brain confirmed that SNAP-25 interacts with the Kv1.1 protein. It 
also has been reported that SNAP-25 blocked Kv outward currents from rat beta-cells by 
approximately 40% (MacDonald et al.2002d). But when  Kv2.1 channels had been functionally 
knocked out using a dominant-negative approach,  SNAP-25 had no effect on outward currents in 
beta cells anymore. It was determined that the inhibitory effect of SNAP-25 was specific to Kv2.1 
in primary rat beta cells as compared to other Kv channels. It also has been shown that the C-
terminus of the channel associates to syntaxin. The study  shows that overexpression of syntaxin 
1A disrupts membrane targeting of cloned Kv2.1 through an interaction with the C-terminus and 
reduces Kv outward currents in rat beta cells (Leung et al.2003).  
 
1.3.3.2     Cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) 
 
         The cyclic adenosine monophosphate/protein kinase A (cAMP/PKA)-signalling pathway 
has been implicated in the regulation of Kv channels (Choquet et al.1987). Elevation of 
intracellular cAMP modulates Kv channels, induces a rapid decrease in the peak potassium 
outward current in murine lymphocytes (Choquet et al.1987), GH4C1 pituitary cell line (Chung 
et al.1995), and a human melanoma cell line (Nilius et al.1992). But the opposite result was 
observed in cardiac myocytes (Walsh et al.1988). An increase in Kv channel outward current was 
induced by epinephrine which can induce inhibition of the glucose-dependent increase in [Ca2+]i 
in ob/ob and wild-type mouse beta cells (Fournier et al. 1993) as the effect is reversed by TEA. 
 20 
Isoproterenol also increases the ultrarapid delayed rectifier K+ current (Ikur, appears to 
correspond to Kv1.5 cloned channels) in human atrial cells in a concentration-dependent manner 
(Li et al.1996). It seems that hormonal modulation of Kv currents is physiologically important for 
diverse cell function. Application of 8-Br-cAMP to Kv 2.1 expressed in Xenopus oocytes causes 
a voltage-independent elevation of current amplitude, whereas application of PKA leads to a 
reduction in Kv2.1 current (Wilson et al.1994).  
 
1.3.3.3    Glucagon-like peptide-1 (GLP-1) 
 
        Beta cell Kv channels are the targets of the G-protein coupled glucagon-like peptide-1 (GLP-
1) receptor, which takes part in glucose metabolism and is physiologically linked to the 
modulation of insulin secretion (MacDonald et al.2002a). MacDonald and his colleagues have 
found that GLP-1 and the GLP-1 receptor agonist exendin-4 inhibit Kv outward currents by 
approximately 40% in rat beta cells using patch clamp in the whole-cell configuration. This  
prolongs the time-course of beta-cell repolarisation (MacDonald et al.2002b).  Additionally, it 
has been shown that the mechanism may involve activation of phosphatidylinositol-3-kinase 
(PI3-K) gamma (Li et al.2006). 
 
1.3.3.4     NADPH and others 
 
         In rat pulmonary artery smooth muscle cells thromboxane A(2) (TXA(2)) analog U46619 
inhibits Kv currents, an effect that is strongly prevented by the NADPH oxidase inhibitor 
apocynin (Cogolludo et al.2006). It suggests activation of NADPH oxidase and the subsequent 
production of hydrogen peroxide are involved in the Kv channel inhibition. The study from 
MacDonald et al (MacDonald et al.2003a) demonstrates that intracellular NADPH/NADP+ ratio 
can increase the intracellular redox potential. This causes beta-cell Kv2.1 currents to inactivate 
quickly and completely. This may be important since the metabolic generation of NADPH could 
reduce the efficacy of Kv channels in repolarising the beta-cell. Research group of Ullrich has 
demonstrated, that activity of Kv1.5 can ben upregulated through SGK1 stimulated by 
dexamethasone (Ullrich et al. 2005b).  
 
1.4    Voltage-gated calcium (CaV) channel 
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         Voltage-gated calcium (CaV) channels are ubiquitously expressed in humans and animals. 
They are found in a variety of cells including excitable cells and some nonexcitable cells (Yang 
et al. 2005b). 
 
1.4.1   Structure and function 
 
         CaV channels have been divided into three families, CaV1, CaV2, and CaV3, consisting of 
closely related members (Ertel et al.2000). CaV channels are almost all composed of the CaVα1, 
CaVβ, and CaVγ subunits; some also contain the CaVα2 δ subunit (Takahashi et al.1987; 
Glossmann et al.1987; Hosey et al.1987; Leung et al.1987) (see Fig. 8.). In this complex, only the 
Ca
 Vα1 subunit is large enough to contain four homologous transmembrane domains forming a 
Ca2+ conducting pore (Takahashi et al.1987). Other subunits, CaVβ, CaVγ and CaVα2 δ subunits, 
are referred to as auxiliary subunits. 
 
 
 
 
 
Fig. 8. A structural model of CaV channels: CaV channel subunit assembly in the plasma 
membrane. Pore-forming subunits CaVα1 complex with auxiliary subunits CaVβ, CaVγ and CaVα2 
δ to form functional CaV channels in the plasma membrane (from Yang et al.2006). 
 
         The conformational change of CaV channels begins from an impermeable state to a highly 
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permeable pore is triggered by membrane depolarization. The highly permeable pore enables the 
rapid influx of extracellular Ca2+ into the cytosol where Ca2+ serves as a second messenger  
coupling electrical signaling to Ca2+-dependent protein-protein interactions and enzymatic 
reactions (Catterall et al.2000).  
          CaV channels  mediate Ca2+ influx in various cell types throughout the body. It controls a 
diverse range of cellular processes including exocytosis, endocytosis, muscle contraction, 
synaptic transmission, and metabolism (Catterall et al.2000; Berridge et al.1998). CaV channels 
play an important role in beta cell physiology and pathophysiology as they take part in the 
process of  glucose-mediated insulin secretion (Yang et al.2005b). Point mutation in the human 
CaV1.2 gene results in excessive insulin secretion (Splawski et al.2004). Trinucleotide expansion 
in the human CaV1.3 and CaV2.1 gene is revealed in a subgroup of patients with type 2 diabetes. 
           It has been shown that the  increase of beta cell CaV channel activity and/or of channel 
density results in enhanced insulin exocytosis and more efficient regulation of glucose 
homeostasis (Yang et al.2005a). On the other hand, the decrease of CaV channel activity and/or of 
channel density causes inhibition of  insulin secretion and glucose intolerance. Reduced CaV 
channel activity has been associated with type 2 diabetic patients (Roe et al.1996b; Iwashima et 
al.1993; Sharp.1996). Beside the control of insulin secretion, beta cell CaV channels are also 
involved in beta cell development, survival, and growth (Namkung et al.2001; Jing et al.2005; 
Sjoholm.1995; Popiela et al.1991). 
          Glucose metabolism in the beta cell leads to an increase in ATP production resulting in 
closure of KATP channels, depolarization of the plasma membrane, opening of CaV channels, and 
thereby release of insulin. Beta cell CaV channels devote themselves to maintain a satisfactory 
concentration of Ca2+. Inappropriate regulation of beta cell CaV channels causes beta cell 
dysfunction and even apoptosis as demonstrated in both type 1 and type 2 diabetes (Roe et 
al.1996b; Namkung et al.2001; Jing et al.2005). 
 
1.4.2   Regulation of Cav channel 
 
          PI3K is involved in CaV channel modulation. Expression of PI3Kγ massively enhances 
current density without altering activation and inactivation kinetics of CaV1.2/β2α channels 
expressed in COS-7 cells (Viard et al.2004). 
         Activation of PKA increases CaV1 channel activity in mouse pancreatic beta-cells as 
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demonstrated by the use of the perforated-patch whole-cell configuration (Kanno et al.1998; 
Gillis et al.1993; Ammala et al.1993).  
         In the mouse pancreatic beta cell, acute application of a PKC activator does not affect CaV 
channel activity. However, Ca2+ influx through beta-cell CaV channels dramatically decreases 
after deprivation of PKC (Arkhammar et al.1994). 
         Inhibition of Serine/threonine protein phosphatases (PPs) with okadaic acid can slightly 
increases CaV channel activity in mouse pancreatic beta-cells. However, after  activation of PKA 
with forskolin, the activity of Cav channel was significantly enhanced by okadaic acid (Sim et 
al.2003). 
         The regulation of pancreatic beta-cell CaV channels by G protein-coupled receptors has 
been also reported (Ammala et al.1992; Isaev et al.2004; Scholze et al.2001). Activation of 
glucagon receptors has been found to regulate CaV channels in the insulin-secreting cell line HIT 
cells and an increase in [Ca2+]i in response to glucagon was demonstrated (Rajan et al.1989) . 
Instead of glucagon receptors,  the glucagon-like peptide-1 (GLP-1) receptor has become a 
pharmaceutical target in the treatment of type 2 diabetes. The activity of GLP-1 receptor induces 
glucose-induced insulin release at least in part through enhancement of beta-cell CaV channel 
activity. The effect is characterized by an increase in CaV current amplitude and a positive shift in 
voltage-dependent inactivation (Salapatek  et al. 1999). 
        Elevated FFAs (free fatty acids) can also affect  beta-cell  CaV channel activity.  
Extracellular administration of palmitate at a concentration of 1 mM on top of 15 mM glucose 
further increases [Ca2+]i in mouse islets. Simultaneously, patch clamp measurements show 
increases in whole-cell CaV currents and cell capacitance by extracellular administration of 
palmitate (Olofsson  et al.2004). 
 
 
1.5     Na+ channels 
 
 
         Voltage dependent Na+ currents can be identified in pancreatic beta-cell by their rapid 
activation and inactivation during a maintained depolarization and by the sensitivity to the Na+-
channel blocker tetrodotoxin (TTX) (Plant.1988; Rorsma et al.1986; Satin et al.1988; Pressel et 
al.1990; Hiniart et al.1988). Glucose-stimulated electrical activity in canine beta-cells is 
abolished by TTX indicating a significant role for Na+-currents in beta-cell electrical activity, and 
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thus possibly insulin release, in this species (Pressel et al.1990). 
 
 
1.6 Cl-  channels                            
   
        Kinard and Satin reported the first time that insulin-secreting cells have a Cl- channel current 
(Kinard et al.1995). The current is activated by hypotonic conditions, glyburide and intracellular 
cAMP. They proved that the channel current is mediated by Cl- channels, since replacing [Cl-]o 
with less permeant aspartate reduces current amplitude and depolarizes its reversal potential. Cl- 
channel activation would be expected to depolarize islet membrane potential. This anion-
permeable pancreatic islet beta cell Cl- channel is an outwardly rectifying Cl- channel which 
mediates a large inward current. The channel is activated by cell swelling (induced by the 
application of hypotonic solution) or by a rise in intracellular cAMP (Kinard et al.1995). 
 
 
1.7    Ion channel activities and apoptosis in beta cell 
 
 
        Apoptosis is reported for the first time by Kerr et al in 1972 (Kerr et al.1972). This term is 
often called "programmed cell death" as it is an innate response of the cell which protects the rest 
of the organism from a potentially harmful agent and this leads to a variety of morphological 
changes, including blebbing, changes to the cell membrane such as loss of membrane asymmetry 
and attachment, cell shrinkage, nuclear fragmentation, chromatin condensation, formation of 
“apoptotic bodies” and chromosomal DNA fragmentation (Kerr et al.1965; Kerr et al.1972; 
Wyllie et al.1980; McConkey et al.1998). In contrast to apoptosis, necrosis is characterized by a 
dramatic increase in cell volume and rupture of the plasma membrane (Gores et al.1990). This 
release of the dying cells contents into the extracellular space can cause further tissue damage by 
affecting neighboring cells or by attracting proinflammatory cells (Haslett et al.1992) (see Fig. 
10.). 
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Fig.10. Hallmarks of the apoptotic and necrotic cell death process. Apoptosis includes 
cellular shrinking, chromatin condensation and margination at the nuclear periphery with the 
eventual formation of membrane-bound apoptotic bodies that contain organelles, cytosol and 
nuclear fragments and are phagocytosed without triggering inflammatory processes. The necrotic 
cell swells, becomes leaky and finally is disrupted and releases its contents into the surrounding 
tissue resulting in inflammation (Modified from Van Cruchten et al. 2002). 
 
 
        Apoptosis is one of the main types of programmed cell death that occurs during several 
pathological situations in multicellular organisms and builds up the mechanism of cell 
replacement, tissue remodeling, and removal of damaged cells. In both type 1 and type 2 
diabetes,  beta cell death is thought to occur by apoptosis. The mechanism have been to be 
triggered by specific proteases(so called caspases) (Specifically, activation of a family of 
intracellular cysteine proteases ) (Alnemri et al.1996). Several mediators are involved in the 
activation of apoptosis, including death receptor activation, oxidative stress (McConkey et 
al.1994) and Ca2+. 
        Animal models of diabetes suport that Fas/FasL system, perforin, TNF, or interleukin (IL)-
1β as effectors of apoptotic islet cell death (Chervonsky et al.1997; Itoh et al.1997; Kagi et 
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al.1997; Kagi et al.1999).  
        Ca2+ influx and subsequent Ca2+-dependent apoptotic signals are involved in beta-cell death 
(Choi et al.2007; Iwakura et al.2000). Activation of L-type Ca2+-channels is associated with DNA 
fragmentation and induces apoptosis and specific blockers of these channels prevent the 
activation of endonuclease was prevented (Juntti-Berggren et al.1993). Sustained high 
concentrations of glucose cause increases in the cytosolic Ca2+ and oligonucleosomal DNA 
fragmentation (Efanova et al.1998). Effect of high glucose–induced DNA fragmentation was 
inhibited by diazoxide, an opener of KATP channels that hyperpolarizes beta-cell membranes. 
Diazoxide treatment indeed has been found to elevate Bcl-2/Bax ratio accordance to ameliorate 
the insulin secretory capacity and action (Huang et al.2007). Chronic exposure to Sulfonylureas 
(glibenclamide, tolbutamide and nateglinide) accelerates apoptotic beta-cell death (Takahashi et 
al.2007).  
          The major function of beta-cells is to synthesize and secrete of insulin. Apart from insulin, 
beta-cells also produce amylin (Moore et al.1991), known as islet amyloid polypeptide (IAPP). 
Amylin functions as part of the endocrine pancreas and contributes to glycemic control.  
          IAPP polymerizes upon section and forms insoluble extracellular plaques. It deposits  up to 
70-90% of patients with type 2 diabetes (T2DM) (Clark et al.1990; Clark et al.1996). More and 
more evidences suggest that abnormal aggregation of IAPP has a role in beta-cell death in 
T2DM, but the mechanism remains unclear. Recent study suggests that amyloid induces an 
increase in K(V)3.4 and caused an increase in I(A) current amplitude carried by K(V)3.4 channel 
subunits in NGF-differentiated PC-12 cells and hippocampal neurons (Pannaccione et al.2007). 
In human neuroblastoma cell line (SK-N-SH cells), L-type calcium channel blocker nifedipine or 
decreased extracellular Ca2+ concentration blocked amyloid-beta induced cell death (Neurochem. 
2004). In another research in beta-cells found reverse results: neither the Ca2+ channel blocker 
verapamil nor a cytosolic Ca2+ buffer protect beta-cells from human amyloid(hA)-evoked 
apoptosis (Bai et al. 1999). These results suggest that alterations in cytosolic Ca2+ homoeostasis 
do not contribute to the pathway of apoptosis evoked by hA in beta-cells. The role of ion channel 
activity and apoptosis induced by amyloid in beta-cells remains elusive.   
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2.    AIM OF THE STUDY 
 
         
        Membrane ion channels regulate the biological function of beta-cells. While pathological 
changes in ion channel activities link to  T2DM. 
        This study was undertaken to elucidate possible mechanisms that inhibit insulin secretin and 
may be involved of apoptotic cell death. For this purpose, the patch clamp method was used to 
examine ion channel activities in isolated mouse islet cells. As glucose-induced changes of 
membrane potential depend on intact cellular metabolism. The perforated patch clamp 
configuration was used to examine membrane potential changes. Effects on ion channels and 
whole cell current were examined with the standard whole cell configuration.  
         In the first part the role of PI3K in the regulation of membrane potential was analysed by 
the use of pharmacological inhibitors and with  reduced expression of 80% 3'-phosphoinositide-
dependent kinase-1 hypomorphic mice (PDK1hm). 
        The second set of experiments elucidates effects of amyloid peptides on ion currents in 
insulin secreting cells. A special focus of this study was to examine the role of ceramide by the 
use of the cells isolated from the acid sphingomyelinase kock-out (ASM-KO) mice. 
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3.   MATERIALS AND METHODS 
 
3.1   Cell preparation 
          
3.1.1    Mouse islets isolation 
 
        In this study, mice of the strain C57BL6/NCrl, phosphoinositide-dependent kinase-1 
hypomorphic mice (pdk1hm ), pdk1wt, acid sphingomyelinase knock-out (ASM-KO)ASM (-/-) and 
wild type littermates ASM (+/+) mice aged from 3-6 months were used in all experiments. They 
were killed by inhalation of CO2 . After mouse desinfection, a long cross incision was cut on the 
abdomen, exposing the opening of the general bile duct in the surface of  the duodenum. The 
right and left sides of the opening were knotted and then the termination of the bile duct with the 
gallbladder was knotted as near to the liver as possible. A small incision on the opening was cut 
out and used for injection of  3 ml collagenase solution (see Tab. 4). After successful injection 
and  swelling of the pancreas, it  was cut out from other adjacent organs and tissues. Collagenase 
digestion was performed for 10 minutes at 37°C in a water bath. The procedure was terminated 
by addition of  30 ml ice-cold Hank’s solution (see Tab. 3). Thereafter the pancreatic fragments 
were sedimented by centrifugation (150 g for 1 minute at RT) and the supernatant removed. The 
tissue pellet was again resuspended in Hank’s solution up to 30 ml. After 1 minute centrifugation, 
the pellet was resuspended in 3-6 ml ice-cold Hank’s solution and sieved through a tea sieve in a 
clean Ø 9 cm pertri dish with a black bottom. White islets were isolated from exocrine tissue 
under a dissection microscope and collected by hand selection. In avarage 126.19 ± 6.48 islets 
were isolated from a mouse (n = 207 preparations).  
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Tab. 3. Ingredients of isolating solutions of mouse islet cells  
 
Compositions:  
Hank’s stock Solution(4×)1L Hank’s stock Solution(1×)1L 
Compound Unit (g) Concentration (mM) Compositions Concentration (mM) 
NaCl 32 547.5 NaCl 136.88 
KCl 1.6 21.46 KCl 5.36 
CaCl2×2H2O 0.74 5.03 CaCl2×2H2O 1.26 
MgSO4×7H2O 0.8 3.25 MgSO4×7H2O 0.81 
Na2HPO4×2H2O 0.24 1.35 Na2HPO4×2H2O 0.34 
KH2PO4 0.24 1.76 KH2PO4 0.44 
NaHCO3 1.4 16.67 NaHCO3 4.17 
HEPES 9.5 39.86 HEPES 10 
PH=7.25   PH=7.25  
   
Preparation: 
       Hank’s  solution Collagenase solution 
Compositions volume Concentration (mM) Compositions volume 
Hank’ stock sol. 100 ml  Without BSA Hank’ sol. 13 ml 
H2O 300 ml  1M CaCl2 70 µl 
Glucose 0.22 g 3.05 Collagenase 14.1 mg 
BSA 1.16 g    
PH=7.25     
 
 
 
       
3.1.2    Primary beta cells preparation and culture 
 
        After collection of islets, sterile 10 ml ice-cold PBS (Ca2+/Mg2+-free, pH=7.2, Gibco- cat#. 
20012-068) was added. After centrifugation (150 g for 1 minute at RT), PBS was removed and 
300-400 µl trypsin solution (1/4 dilution with Ca2+/Mg2+-free PBS of 0.5 g/L of trypsin) was 
added. The islets were then kept for 4 minutes at 37°C. The digestion was stopped by addition of 
10 ml culture medium. After centrifugation (300 g for 4 minutes at RT), the supernatant was 
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removed and culture medium added to the cell pellet. After 4 minutes of centrifugation, the 
supernatant was removed and all the pellet resuspended in a small volume of new culture medium 
(200 µl/100 islets). 20-25 µl of the suspension were dropped in the middle of the petri dishes for 
patch clamp experiment. Cells were grown in  RPMI 1640 supplemented with 10% fetal calf 
serum (FCS) (v/v), 10 mM Hepes,  1 mM Na-pyruvate, 2 mM L-glutamine, 50 i.u. penicillin/ml 
and 50 µg streptomycin/ml (see Tab. 4). For fluorescence microscopy cells were seeded on glass 
cover slips coated with  poly-L-ornithine. The dishes were placed about 60-120 minutes in the 
incubator in order to get the cells attached on cover slip or dish bottom. The dishes were then 
filled with 2 ml culture medium. About 8-10 dished were prepared from 100 islets (Ullrich et 
al.2005). Cells were kept in incubator 1-3 days according to different experiments and were 
treated as indicated in each experiment.  
 
Tab. 4: Ingredients of  islet cell culture medium 
 
      Cell culture medium 
 
Total volume ml 
RPMI 1640 450 
HEPES 1M 5 
Pyruvate (100mM) 5 
Penicillin (5000 i.u./ml)/Streptomycin(5000µg/ml) 5 
FCS 50 
L-Glutamin (200mM) 5 
             
      
                    
 
3.2    Chemicals and reagents 
 
 
Adrenaline  Sigma-Aldrich, Deisenhofen, Germany 
Alexa fluor 488 anti-mouse IgG Invitrogen, Paisley, UK 
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4-Aminopyridine Sigma-Aldrich, Deisenhofen, Germany 
Amphotericin B from Streptomyces Sigma-Aldrich, Deisenhofen, Germany 
Amyloid β-protein fragment 1-42 Sigma-Aldrich, Deisenhofen, Germany 
Amyloid β-protein fragment 42-1 Bachem 
Collagenase NB8 Serva, Heidelberg, Germany 
Dexamethasone Sigma-Aldrich, Deisenhofen, Germany 
4′,6′-diamidino-2-phenylindole (DAPI) Sigma-Aldrich, Deisenhofen, Germany 
Diabetes associated peptide amide human (IAPP) Sigma-Aldrich, Deisenhofen, Germany 
Dihydroceramide C2 Sigma-Aldrich, Deisenhofen, Germany 
Dimethylsulfoxide (DMSO) Sigma-Aldrich, Deisenhofen, Germany 
D-myo-Phosphatidylinositol3,5-bisphosphate (PIP2) Echelon, Salt Lake City, U.S.A 
In Situ cell death detection kit Fluorescein Roche, Mannheim, Germany 
Insulin from bovine pancreas Sigma-Aldrich, Deisenhofen, Germany 
Insulin-like growth factor-1 (IGF-1) Sigma-Aldrich, Deisenhofen, Germany 
Leptin from mouse Sigma-Aldrich, Deisenhofen, Germany 
LY-294002 hydrochloride Sigma-Aldrich, Deisenhofen, Germany 
Monoclonal Antibody to Ceramide(MID 15B4) Alexis, Lörrach, Germany 
N-Acetyl-D-Sphingosine (C2) Sigma-Aldrich, Deisenhofen, Germany 
Ouabain Sigma-Aldrich, Deisenhofen, Germany 
Poly-L-ornithine Sigma-Aldrich, Deisenhofen, Germany 
Rapamycine Sigma-Aldrich, Deisenhofen, Germany 
RU-486 Sigma-Aldrich, Deisenhofen, Germany 
Tetraethylammonium chloride (TEA) Sigma-Aldrich, Deisenhofen, Germany 
Tolbutamide Sigma-Aldrich, Deisenhofen, Germany 
Wortmannin Sigma-Aldrich, Deisenhofen, Germany 
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        Leptin, insulin and IGF-1 were prepared as stock solutions in normal saline and further 
diluted in bath solution containing  0.1%(w/v) bovine serum albumin as a carrier. C2, Di-C2, 
dexamethasone, wortmannin and LY294002 were stored as stock solutions in DMSO. 
                                           
                                                                                                      
3.3    PATCH CLAMP EXPERIMENTS 
 
     The patch clamp technique allows to measure currents through cell membranes using the 
voltage clamp mode of the technique. Membrane potential can be measured in the current clamp 
mode.  
 
3.3.1    Voltage Clamp 
 
        The voltage clamp technique allows to measure current that flows through the membrane at 
any particular potential hold at a constant value. The principle of the technique is to inject a 
current which is equal in amplitude but opposite in sign to the current flowing across the cell. 
This results in no net current flow across the membrane, and the membrane potential remains 
constant. Therefore, by measuring the current, which has to be injected to clamp the potential, the 
current flowing across the membrane can be determined. By measuring currents at different 
clamped membrane potentials it is then possible to characterize voltage-dependency ion currents. 
 
3.3.2    Patch Clamp 
 
        The use of the voltage clamp technique was further extended by the invention of the patch 
clamp technique almost thirty years ago by Neher and Sakmann. Neher and Sakmann wanted to 
record from a tiny area (the so-called patch) of a surface membrane by pressing a fire-polished 
pipette against a living cell. In 1976 they reported the first single-channel current recording of  an 
acetylcholine-activated channel (Neher et al.1976). This technique allows direct electrical 
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measurements of ion channel currents while simultaneously controlling the cellular membrane 
potential. In 1981 they showed that a clean glass pipette can fuse to cell membrane to form a seal 
of an unexpected high resistance and mechanical stability (Hamill et al.1981) . This seal was 
called gigaseal since it can have an electrical resistance as high as 109. 
 
      The figure below is a conceptual diagram of the patch-clamp setup.  
 
 
 
 
Fig.11.  Conceptual diagram of the patch-clamp setup (from Crumb WJ et al. 2003). 
 
           A fine-tipped glass capillary is used to make contact with a biological cell membrane  to 
form a high resistance seal. Conventionally, this requires the use of a microscope, and a 
micromanipulating device connected to the capillary. A sensing electrode inside the capillary is 
connected to a high-gain, trans-impedance amplifier circuit that converts the current flowing 
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through the electrode to an output voltage. The purpose of the high-resistance seal is to insure 
that the flow of current from the sensing electrode inside the capillary to the ground electrode in 
the bath solution is predominantly due to ions flowing through the cell membrane. 
        One of the advantages of the patch clamp technique is that it allows measurements on very 
small cells such as mammalian cells. The basic principle of this technique is that a fluid filled 
micropipette containing a silver/silver chloride electrode is brought in contact with the cell 
membrane. By applying gentle suction to the pipette, a giga-seal is formed between the pipette 
and the cell membrane.  
       This giga-seal permitts four distinct recording configurations: The cell-attached patch mode, 
the inside-out patch mode, the outside-out patch mode and the whole-cell patch mode (see 
Fig.12). When the pieptte is sealed to the cell membrane, single channels can be recorded in the 
on-cell or cell-attached patch mode.  
      After formation of the giga-seal, further suction can rupture the patch of membrane under the 
tip of the micropipette, providing access for the microelectrode to the interior of the cell; this 
situation is termed the whole cell configuration. The whole cell configuration allows to measure 
the sum of all of the ion channels activities in the cell membrane (the whole-cell current or 
macroscopic current). The standard whole cell configuration allows manipulation of the 
intracellular solution, but has the concomitant disadvantage that soluble cytosolic constituents are 
lost from the cell by dialysis with the pipette solution. The perforated patch whole-cell 
configuration avoids this problem.  
       To prevent the disadvantage of  “wash-out” (for instance, by loss of second messengers, 
changes in enzyme activity or modification of the phosphorylation state) by conventional whole-
cell configuation, the perforated patch (also called permeabilized patch) was developed (Horn et 
al.1988) . The perforation of the patch of membrane under the pipette is produced by pore-
forming compounds added to the pipette solution. Most of them are polyenes, such as nystatin 
and amphotericin B (AmB) are often used (see Fig. 13). 
        In whole-cell configuration, the part of the membrane inside the capillary is disrupted, 
thereby creating a low-resistance pathway between the sensing electrode and the cytoplasm. 
From an electrical viewpoint, this puts the sensing electrode in the glass capillary inside the cell. 
This allows for the control of the cell membrane via the non-inverting input of the trans-
impedance amplifier. The current measurement  between the sensing electrode and the bath 
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electrode is then the resultant sum of all of the ion currents in the remainder of the cell, which, 
due to the small geometry of the capillary, comprises the majority of the ion channel currents in 
the "whole cell" (Hille.1992;  Hamill et al.1981).  
        Furthermore, by retracting the micropipette in either the cell-attached or the whole-cell 
configuration, a small patch of membrane can be isolated in either inside-out or out-side out 
configuration. These two configurations give the opportunity to measure single channel currents 
under circumstances facilitating pharmacological manipulations from both the cytoplasmic and 
extracellular side of the membrane. 
       One disadvantage of current implementations of the patch-clamp technique is the high level 
of manual intervention required to make the measurements, which severely restricts the 
measurement throughput. Typically, an experienced scientist can patch and make measurements 
from 10-20 individual cells per day. This level of measurement throughput is far below that 
required for secondary (hundreds to thousands / day) or primary (thousands to tens of thousands / 
day) pharmaceutical drug screening and has limited the ability to screen ion channel targets with 
high fidelity.  
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Fig.12: Schematic representation of the procedures that lead to the different patch clamp 
configurations. The on-cell configuration is obtained by forming a giga-seal between the patch 
pipette and the cell membrane. Withdrawal of the pipette from the cell produces an inside-out 
patch. If the patch is destroyed in the on-cell configuration, the standard whole-cell configuration 
is obtained. Withdrawal of the pipette from the standard whole-cell configuration produces an 
outside-out patch (from Hamill et al. 1981). 
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Fig.13: Schematic representation of the procedures that lead to the conventional whole-cell 
configuration and permeabilized whole-cell configuration.  Perforated patch whole-cell 
configuration is produced if the patch is permeabilised instead of destroyed (from Hamill et al. 
1998). 
 
 
 
3.3.3    Patch Clamp Experiment 
 
3.3.3.1    Pipette 
 
        Pipettes can be made from many different type of glass. Glass capillaries are available from 
soft or hard glasses. Hard glass pipettes often have a narrow shank after pulling and consequently 
a higher resistance. Hard glasses tend to have better noise and relaxation properties. Borosilicate 
glass is one kind of hard glass and has low dielectric loss and is desirable for the lowest-noise 
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recordings. During the experiment borosilicate glass capillaries (GC150TF-7.5, 1.5mm 
O.D.×1.17mm I.D. Harvard Apparatus LTD, UK) were used. The pipettes were pulled by DMZ 
universal puller (Zeitz, Augsburg, Germany) from borosilicate micropipettes and heat-polished. 
Pipettes are pulled in two stages: the first to thin the glass to 200-400 µm at the narrowest point 
over a 7-10 mm region, and the second to pull the two halves apart, leaving clean , symmetrical 
breaks. Both halves can be used after heat polish. 
 
3.3.3.2 Solutions 
 
Tab. 5:  Ingredients of solutions during patch clamp experiments 
 
Bath solution 
compositions mmol/l 
NaCl 145 
KCl 5 
MgCl2.6H2O 1 
CaCl2 2.5 
Hepes 10 
Adjust with NaOH PH 7.4 
Glucose 5.6 
  
                            Pipette solutions             
For K channel exp.:  
compositions mmol/l 
K-Gluconat 95 
KCl 30 
MgCl2 ·6 H2O 1 
EGTA 3 
CaCl2 1 
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NaH2PO4 1.2 
Na2HPO4 4.8 
 
For perforated patch measurements: 
Amphotericin B 1 mg/ml was prepared before use and was protected from light. 
 
 
3.3.3.3    Experimental procedures 
 
        The culture dish with  attached primary mouse islet cells was mounted onto the stage of an 
inverted microscope. The volume of the recording chamber was 0.2-0.3 ml. Solutions were 
superfused through the chamber at a rate of 5-6 ml/min. The experiments were carried out at 
room temperature (20°C). Patch clamp experiments were performed in the whole-cell 
configuration by the use of an EPC9 patch-clamp amplifier (HEKA Electronic Company, 
Germany). Pipettes had a resistance of 4.0-6.0 Ω when filled with the pipette solution .  
        When the patch-pipette was approached to the cell, the resistance increased to 10.0-16.0 Ω. 
After applying a slow and gentle suction to the pipette, a tight seal (2-20 GΩ) was established in 
normal bath solution, the cell-attached configuration was formed. After a strong and sudden 
suction, the patch of cell membrane broke and a conventional whole-cell configuration was 
formed. For perforated patch configurations, a pipette solution containing amphotericin B was 
used. After formation of a cell-attached configuration, perforated whole-cell configuration was 
formed slowly after 5-10 minutes.  
         Only stable current and voltage measurements were used  for analysis, i.e. when the access 
resistance was stable and lower than 20 MΩ. 
 
3.3.3.4    Recording  and analysis 
 
         Experiments were performed using whole-cell current clamp recording to monitor 
membrane potential and using whole-cell voltage clamp mode to examine membrane currents. 
During voltage clamp recordings, the membrane potential was held at -70 mV, and 20 mV steps 
of 400 ms duration were applied every 1 s (range -100 mV to 80 mV). Current and voltage were 
measured using an EPC9 amplifier (Heka Elektronik, Germany), and currents evoked in response 
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to the voltage step protocol were analyzed using Pulse+Pulse Fit V8.53 software (Heka 
Elektronik, Germany). 
        
3.4    Measurement of cell death 
 
        For fluorescent staining, primary beta cells were plated onto poly L-ornithine-coated glass 
cover slip. Cells obtained from approximate 100 islets were distributed onto 6 glass cover slips 
and were seeded at a density of 1-1.2х104  cells/dish. 
 
3.4.1    Poly-L-ornithine coating 
 
         In order to improve the attachment of the cells to glass, the glass cover slips (22 х 22 mm) 
were coated with 0.01% L-ornithine solution (cat. No.84957, Sigma) diluted 1:10 with sterile 
PBS (Ca2+/Mg2+-free). The poly-L-ornithine solution (1 ml) was kept on the cover slips for 10-15 
minutes. Thereafter the cover slips were washed one time with PBS and the solution completely 
removed. Finally the cover slips was dried before seeding the cells. 
 
 
3.4.2    DAPI staining of nuclear DNA 
 
        The DAPI staining of nuclei was used to distinguish alive cells from dead cells of which the 
nuclei are smaller, condensed and fractionated. 
        4´-6´-Diamidino-2-phenylindole (DAPI) forms fluorescent complexes with natural double-
stranded DNA. DAPI binds to the minor groove of the DNA strand, the interaction being 
stabilized by hydrogen bonds between DAPI molecules and base pairs. After seeding, primary 
beta cells were cultured for 24 hours before treatment. After cells were treated for 1-2 days, 
DAPI stainging was performed in tissue culture. After removing the culture medium with test 
substances, cells were fixed and permeabilized 2 ml DAPI (0.1µg/ml ) solution per dish was 
added and kept in dark for 10 minutes. The dishes were washed 1 time with PBS.  Then the cells 
were washed with nomal water and dried with paper towel. At last moviol 20 µl was put in the 
middle of the object slides just before the cover slip was placed on the moviol drop (cells are 
between glass and slip). Then all slides were stored in a dark box until measurement of 
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fluorescence with a fluorescence microscope. 
 
 
3.5    TUNEL (terminal dUTP nick-end labelling) assay of apoptotic cells 
 
        Terminal dUTP nick-end labelling (TUNEL) assay specifically detects DNA fragmentation 
which is characteristic for apoptotic cells. One of the hallmarks of late stage apoptosis is the 
fragmentation of nuclear chromatin which results in a multitude of 3´-hydroxyl termini of DNA 
ends. This property can be used to identify apoptotic cells by labelling the DNA breaks with 
fluorescent-tagged deoxyuridine triphosphate nucleotides (Fluorescein-dUTP). The enzyme 
terminal deoxynucleotidyl transferase (TdT) catalyzes a template-independent addition of deoxy-
ribonucleoside triphosphates to the 3´-hydroxyl termini of generated DNA strands. Non-apoptotic 
cells do not incorporate much of the F-dUTP because of the absence of these exposed 3´-
hydroxyl DNA ends and remain therefore unstained. 
         For TUNEL assay a In situ cell death detection kit, Fluorescein (cat.no. 11684795910, 
Roche Diagnostics) was used. The incorporated fluorescein-tagged nucleotides were detected by 
fluorescence microscopy, using an excitation of 488 nm and emission of 515-565 nm. 
         After 1 to 3 days of treatment, cells were prepared for TUNEL-staining, following the 
operating protocol provided by the kit. Shortly, the culture medium was removed and cells were 
fixed for 60-90 minutes in ice-cold paraformaldehyde (4% in PBS). After fixation, cells were 
washed twice with PBS and permeabilised for 2 minutes with 0.1% ice-cold Triton X-100 in 
0.1% sodium citrate-containing PBS. During this step dishes must be kept on ice. The dishes then 
were washed twice with cold PBS and dried out. The TUNEL reaction mixture was carefully 
droped on the cells (50 µl each), the dishes were covered with parafilm and incubated 60 minutes 
at 37°C in the dark. After staining, TUNEL reaction mixture was removed and the dishes were 
washed twice with PBS. Thereafter all nuclei were stained with DAPI, and the samples examined 
under an inverted fluorescence microscope (Zeiss, Germany) by using a 10x objective, an 
excitation of 488 nm and an emission of 515-565 nm. The fluorescent green spots (TUNEL 
staining) in the microscopic field represent the apoptotic nuclei. DAPI staining was visualized 
with UV light using an excitation of 358 nm and emission of 461 nm.   
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3.6    Immofluorescent staining of cellular ceramide  
 
         The cells were cultured as mentioned before. After 24 hours the culture medium was 
replaced by medium without FCS as control group or by medium containing amyloid 0.1 µM. 
The dishes were kept in 37° C incubater for 30 min. Then the solution was sucked off and ice-
cold paraformaldehyde (4% in PBS) added for 1 hour. After fixation the cells were washed twice 
with PBS and permeabilised for 2 minutes with 0.1% ice-cold Triton X-100 in 0.1% sodium 
citrate-containing PBS. During this step dishes were kept on ice. The dishes were then washed 
twice with cold PBS and dried out. To reduce non-specific binding PBS with 10% FCS was 
added to each dish and the dishes kept at RT for 45 minutes. Then cells were incubated with  
anti-ceramide antibody (monoclonal antibody against ceramide mouse IgM, ALEXIS, Germany). 
A drop of 100 µl (10 µl Ab added to 90 µl PBS containing 10% FCS) anti-ceramide antibody was 
placed on to the cells and kept in dark overnight at 4°C. The next day, the cells were washed 3 
times with PBS containing 10% FCS (each wash-time 10 min). Then samples were stained with 
2nd antibody (Alexa Fluor 488 anti mouse IgG , Invitrogen, U.K). The cells were incubated with 
100 µl 2nd antibody (diluted in 1:400 with PBS containing 10% FCS) and kept for 1 h at RT. 
After washing, samples were stained with DAPI and the cover slips embedded with Moviol. 
Ceramide formation was analysed under a fluorescent microscopy (HAL100, Zeiss, Germany) 
using an excitation wavelength of 495-519 nm.  
  
 
3. 7    Data analysis and statistics 
 
        Data are presented as means ± SEM. ANOVA for multiple groups and Student’s t-tests were 
used for statistical analyses as appropriate. P values < 0.05 was accepted to indicate statistical 
significance. 
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4    RESULTS 
 
4.1    Electrical activity in primary mouse single islet cell  
 
4.1.1    Glucose-induced electrical activity in pancreatic beta cells. 
 
        To evaluate how the primary islet cell population was responsive to glucose, glucose-
induced electrical activity was measured after 2-4 days of tissue culture of the cells using the 
amphotericin B technique. This allows to quantify the number of cells responsive to glucose and 
to distinguish beta cells from non-beta cells. 
        Pancreatic islet cells are excitable cells that display electrical activites when stimulation 
occurs. It is well established that the metabolism of nutrient secretagogues such as glucose is 
essential for their action−i.e. the depolarization of the beta cell and the initiation of electrical 
activity (Henquin et al.1984). At glucose concentrations below 3 mM, which do not elicit insulin 
secretion, the beta cell is electrically silent with a resting membrane potential of about - 70 mV 
(see Fig.14A). Raising the external glucose produces a slow depolarization whose extent  
depends on concentration of the sugar (see Fig.14B). At glucose concentrations higher than 7 
mM, that stimulate insulin release, depolarization becomes sufficient to reach the threshold 
potential ( ~ - 50 mV) at which electrical activity is initiated (see Fig. 14C). The individual action 
potentials are shown in more detail in Fig. 14D. 
 
 
 A                                                                         B  
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Fig. 14 : Glucose-induced electrical activity in pancreatic beta-cells. 
A: At 0 mM glucose beta cells are electrically silent with a resting membrane potential of about  
- 70 mV (upper left panel). B: At 5.6 mM glucose beta cells slowly depolarize to about – 60 mV 
(upper right panel). C: Following the increase of glucose concentration to 16.8 mM  was 
sufficient for the cell to depolarize of about -40 mV that reaching the threshold potential to 
initiate action potential. The  plateau of action potential is sustained and continuous (lower left 
panel). D: Individual action potentials are shown with higher time resolution: the duration of each 
action potential is about 200 ms, the peak voltage of the action potential reached +20 mV.  The 
plateau potential was ~ - 40 mV (recording of a cell at 11.2 mM glucose; lower right panel). 
 
 
        Table 6 summarizes the glucose-responsiveness of islet cells. These data show that 78% of 
the islet cells are responsive to glucose.  The elevation of glucose from 5.6 mM to either 11.2 
mM or 16.8 mM initiated action potentials from a similar plateau phase (- 38.50 ± 1.53 mV and   
-38.82 ± 1.07 mV; n= 26 and 38 ) (see Tab. 6). After rising the glucose concentration, action 
potentials were only initiated after 1 minute.  This delay reflects the time that is needed for the 
cell to metabolise glucose and to rise cytosolic ATP concentration. 
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- 40 mV-
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m
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Tab. 6 : Islet cells glucose-responsive experiments. 
 
 Rate N 
Mean 
(Voltage: 
mV) SE 
Initiating 
time 
(seconds) 
Time to 
plateau 
(seconds) 
Total experiments of glucose 
responses 
  213   
  
Total cells examined 
  82   
  
Measurements at 5.6mM 
glucose 
  82 -52.94 1.09 
  
Non-glucose responsive cells at 
5.6mM glucose 
  18 -44.86 2.38 
  
Glucose responsive cells at 
5.6mM glucose 
  64 -55.16 1.15 
  
Measurements at 11.2mM 
glucose 
  32 -41.32 1.51 
  
Measurements at 16.8mM 
glucose 
  50 -44.2 1.62 
  
Total non-glucose-responsive 
cells 
  18 -61.25 1.20 
  
Total glucose responsive cells 
  64   
  
Cells response to 11.2mM 
glucose 
  26 -38.50 1.53 
66.92±7.37 
 
97.31±10.09 
 
Cells response to 16.8mM 
glucose 
 
  
38  
             
-38.82 
 
1.07 
 
62.63±6.93 103.82±10.01 
 
 
Islet cells initiate action 
potential to glucose (>8 mM) 
 78.05% 82   
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4.1.2    Tolbutamide induces action potential in primary mouse single islet cell. 
 
        Certain pharmacological agents such as sulphonylureas block the KATP channel directly. 
Tolbutamide depolarized beta-cell and initiate electrical activity within few seconds (Sturoess et 
al.1985) (see Fig. 15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.15: Tolbutamide induces action potentials in primary mouse single islet cell. During 
AmB perforated whole-cell recording, addition of 100µM Tolbutamide to 5.6 mM glucose 
rapidly elicits depolarization and continuous action potential. 
 
 
 
        In general, tolbutamide-induced action potentials were stable and sustained. The plateau 
phase was at about – 32.82 ± 0.73 mV (n= 93).  The initiation of action potential was rapid and 
started 3.63 ± 0.24 seconds (n= 93) after addition of tolbutamide. 
5.6 mM Glucose
100 µM Tolbutamide
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4.2    Regulation of membrane potential and  current by hormones and peptides  
 
4.2.1    Leptin regulates membrane potential and current via a PI 3-kinase-dependent 
process  in  mouse islet cells. 
 
         It has been shown that injection of leptin into wild type and ob/ob mice significantly 
decreases body weight and serum concentrations of glucose and insulin ( Halaas et al.1995; 
Pelleymounter et al.1995). To examine the direct effect of leptin on channel activity induced by 
glucose and to study the involvement of phosphoinositide 3-kinase (PI3K), leptin was 
exogenously added to the perfused bath solution in the absence and presence of PI3K inhibitors 
LY294002 and wortmannin.  
        Under current-clamp conditions with AmB in the pipette solution (formation of perforated 
whole-cell patch clamp), the mean membrane potential of mouse primary pancreatic beta cell was 
-37.11 ± 0.37 mV (n=38) at 11.2 mM glucose. The application of leptin (100 nM) resulted in a 
hyperpolarization of the plasma membrane  to -54.12 ± 2.31 mV (n=9; P<0.001; Fig. 16A1, A2 
and B). After 5 minutes wash out leptin from the bath solution, membrane potential partially 
reversed (n=4; -42.58 ± 1.27 mV). The hyperpolarization induced by leptin was slow, started  2-3 
minutes after addition of leptin and achieved the maximum after 3-5 minutes. The examination of 
the voltage-clamped currents (Fig. 16C1 and C2) revealed that prior to the application of leptin 
(100nM), the control peak outward current density was 72.11 ± 9.14 pA/pF and increased after 
addition of leptin to 88.84 ± 17.29 pA/pF (n=4; P=0.1518; Fig. 16D1 ). At the same time the 
conductance of the cells increased with leptin from 0.65 ± 0.04 nS to 0.83 ± 0.16 nS (n=4; 
P=0.1574; Fig. 16D2). The application of inhibitors of PI 3K, LY294002 (10 µM; n=6; Fig. 16E 
and 16F) had no significant effect on the resting membrane potential but prevented the leptin-
induced hyperpolarization. The perfusion with LY and leptin was continued for at least 5 
minutes. 
        These data suggest that leptin exerts its hyperpolarizing effect on membrane potential 
through the activation of PI3K pathway. 
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Fig.16: Leptin regulates membrane potential and current via a PI 3-kinase-dependent 
process in mouse islet cells. A1: Representative AmB perforated whole-cell current clamp 
recording of a primary mouse islet cell. The application of leptin (100 nM) resulted in a slow 
change of membrane potential from -37 mV to -50 mV. Membrane potential decreased after 2.5 
minutes and achieved a maximum. After 4 minutes wash-out of the leptin from the bath, the 
effect was reversed. The break corresponds to 3 min. A2: Using the same protocol as above, 
application of leptin resulted in a hyperpolarization from -39 mV to -60 mV. It lasted 2 minutes 
before initiation of response and it achieved a maximum after 3 minutes. After 4 minutes wash-
out of the leptin from the bath, the effect was reversed. The break corresponds to 3 min. B: 
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Arithmetic means ± SEM (n=9) of membrane potential (mV) prior to (white bar) and after 
exposure of the cells to leptin (100 nM; black bar). *** indicates great significant difference 
between leptin and control (P<0.001; two-tailed paired t-test). C1: Original tracings of perforated 
whole-cell recording of membrane current prior to (C1 left measurement) and after addition of 
leptin (100 nM; C1 right measurement). C2: I-V relations of mean current prior to (open 
triangles) and after exposure of mouse islet cells to leptin (100 nM; closed squares). D1: 
Arithmetic means ± SEM (n=4) of peak current density (pA/pF) prior to (white bar) and after 
exposure of the cells to leptin (100 nM; black bar). D2: Arithmetic means ± SEM (n=4) of slop 
conductances (nS) of mouse islet cells prior to (white bar) and after exposure of the cells to leptin 
(100 nM; black bar). E: Original AmB perforated whole-cell current clamp recording of a 
primary mouse islet cell. Application of LY 294002 (10 µM) had no effect on the resting 
membrane potential. Application of leptin (100 nM) after exposure to LY 294002 failed to 
hyperpolarize mouse islet cells. F: Arithmetic means ± SEM (n=6) of membrane potential (mV) 
prior to (white bar) and after exposure of the cells to leptin (100 nM; black bar). LY 294002 
prevented the leptin-induced hyperpolarization in mouse islet cells. 
 
 
4.2.2    IGF-1 regulates membrane potential and current via a PI 3-kinase-dependent 
process in mouse islet cells 
 
        It has been shown that IGF-1 inhibits insulin secretion that has been increased by glucose 
and glucagonlike peptide 1 in an insulinoma cell line ( Zhao et al.1997), in rat pancreas (Fürnsinn 
et al.1994; Leahy et al.1990) and also in isolated beta cells ( Van et al.1990).  As IGF-1 
stimulates PI3K pathways, its effect on membrane potential was examined using the perforated 
whole cell patch clamp configuration as for leptin. 
         The mean membrane potential of mouse primary pancreatic beta cell in the presence of 11.2 
mM glucose was -39.54 ± 2.08 mV(n=8). Following application of IGF-1 (50 ng/ml) the 
membrane slowly hyperpolarized to -53.32 ± 1.07 mV (n=8;P<0.001; Fig. 17A and B) in mouse 
single islet cell. The response to IGF-1 was initiated 3-5 minutes after application. This 
hyperpolarization was not reversed after 15 minutes after remove of IGF-1. The application of the 
PI 3-kinase inhibitors LY294002 (10 µM; Fig. 17C and D) had no significant effect on membrane 
potential but prevented IGF-1-induced hyperpolarization (LY -39.60 ± 1.42mV vs LY with IGF-
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1 -41.06 ± 2.24mV; n=5 respectively ). The perfusion of LY and IGF-1 in combination was 
continued at least 5 minutes. 
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Fig.17: IGF-1 reduced membrane activity via a PI 3-kinase-dependent process in mouse 
islet cells. A: Representative AmB perforated whole-cell current clamp recording of a primary 
mouse islet cell after application of IGF-1 (50 ng/ml). The membrane potential hyperpolarized 
from -36 mV to -57 mV. The response to IGF-1 started 2.5 minutes after application. After 15 
minutes wash-out of IGF-1 from the bath, the effect was not reversed. B: Arithmetic means ± 
SEM ( n=8) of membrane potential (mV) prior to (white bar) and after exposure of the cells to 
IGF-1 (50 ng/ml; black bar). *** indicates very significant difference between control and  IGF-1 
(P<0.001; two-tailed paired t-test). C: Original recording of a mouse islet cell. Application of LY 
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294002 (10 µM) had no effect on membrane potential. Application of IGF-1 (50 ng/ml) after 
exposure to LY 294002 failed to hyperpolarize mouse islet cells. D: Arithmetic means ± SEM 
(n=5) of membrane potential (mV) prior to (white bar) and after exposure of the cells to IGF-1 
(50 ng/ml; black bar). LY 294002 prevented the IGF-1-dependent hyperpolarization in mouse 
islet cells. 
 
 
4.2.3    Exogenous insulin has no significant effect on whole-cell membrane potential in 
mouse islet cells 
 
        To examine whether insulin also hyperpolarizes beta cells, comparable experiments using 
the perforated whole-cell patch clamp have been performed. The mean membrane potential of 
mouse primary pancreatic beta cell was -33.50 ± 3.25 mV (n=3). Following application of 
exogenous insulin (1 µM) had no significant effect on membrane potential (-34.08 ± 3.52 mV; 
n=3; P>0.05; Fig. 18A and B) in mouse single islet cell. The perfusion of the exogenous insulin 
was continued at least 5 minutes. 
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Fig. 18: Exogenous insulin has no significant effect on whole-cell membrane potential in 
mouse islet cells. A: Representative AmB perforated whole-cell current clamp recording of a 
primary mouse islet cell after application of exogenous insulin (1 µM) had no effect on 
membrane potential. B: Arithmetic means ± SEM (n=3) of membrane potential (mV) prior to 
(white bar) and after exposure of the cells to exogenous insulin (1 µM; black bar; P>0.05; two-
tailed paired t-test). 
 
 
 
 
4.2.4    Adrenaline regulates membrane potential and current via a PI 3-kinase-dependent 
and PDK1 process in mouse islet cells.  
 
        That adrenaline (or epinephrine) inhibits insulin secretion and hyperpolarizes beta cells, has 
been demonstrated  decades ago (Fowden 1980; Ullrich et al.1984; Ullrich et al.1985; Ullrich et 
al.1988; Lacey et al.1993; Abel et al. 1996; Ullrich et al.1996; Lehr et al.1997; Kampermann et 
al.2000; Peterhoff et al.2003; Sieg et al.2004; ). However, the mechanism of adrenaline induced 
hyperpolarization is still not completely understood. The following experiments were performed 
to examine whether adrenaline-induced hyperpolarization depends on PI3-kinase activity.  
        Under current-clamp conditions with AmB in pipette solution (formation of perforated 
whole-cell patch clamp) and in the presence of 16.8 mM glucose in bath solution, the mean 
membrane potential of mouse primary pancreatic beta cell was -38.82 ± 1.07 mV (n=38) and 
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action potential were generated. Following application of adrenaline (1 µM) resulted in a 
hyperpolarization to -55.24 ± 1.37 mV (n=16; P<0.001; Fig. 19A and B). 1-5 minutes after wash-
out of adrenaline from the perfusion solution, in 12 out of 16 recordings the effect was reversed 
(n=12; -38.59 ± 2.00 mV; compares with adrenaline P<0.01; recording did not show here). The 
hyperpolarizing response of adrenaline was initiated 10-15 seconds after addition of adrenaline 
and a maximum was achieved after 20-30 seconds. Examination of the voltage-clamped currents 
(Fig. 19C1 and C2) show that prior to adrenaline application (1 µM), the control peak outward 
current density was 41.64 ± 4.61 pA/pF and following exposure to adrenaline a current was 
significantly increased to 58.46 ± 4.49 pA/pF (n=5; P<0.01; Fig. 19D ). Application of the PI 3-
kinase inhibitor LY294002 (10 µM; n=7; Fig. 19E and F) had no significant effect on membrane 
potential but prevented the adrenaline-induced hyperpolarization (LY -40 ± 2.1mV vs LY with 
adrenaline -42.1 ± 2.83mV; n=7 respectively;  P>0.05 ). The perfusion of the combination of LY 
and adrenaline was continued at least 5 minutes. Application of another inhibitor of PI 3-kinase, 
wortmannin (100nM; n=7; Fig. 19G and H), also showed no significant effect on the membrane 
potential, but prevented the adrenaline-induced hyperpolarization (wortmannin -45.71 ± 3.62mV 
vs wortmannin with adrenaline -48.85 ± 3.7mV; n=7 respectively;  P>0.05).   
        The hyperpolarizing effect of epinephrine was also observed in pdk1wt mouse islet cells (Fig. 
19 I and J) but abrogated in pdk1hm mouse islet cells (Fig. 19 K and L). In the presence of 16.8 mM 
glucose application of epinephrine (1 µM) resulted in a significant (P < 0.05) hyperpolarization 
from -40.3 ± 3.6 mV to -53.4 ± 3.2 mV (n = 5) in pdk1wt mouse single islet cells (Fig. 19 I).  In 
contrast, as shown in Fig. 19 I, the application of epinephrine (1 µM) in the presence of 16.8 mM 
glucose did not significantly (P = 0.11) hyperpolarize pdk1hm mouse islet cells (-41.5 ± 1.4 mV  
prior to and -44.6 ±  2.3 mV following epinephrine, n = 7) (Fig. 19 K and L). 
        These results suggest that adrenaline-induced hyperpolarization depends on PI3K and PDK1 
activities. 
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Fig. 19: Adrenaline regulates membrane potential and current via a PI 3-kinase-dependent 
and PDK1 process in mouse islet cells. A: Representative AmB perforated whole-cell current 
clamp recording of a primary mouse islet cell after application of adrenaline (1 µM) induced 
hyperpolarization from -41 mV to -59 mV. The response started 10 seconds after addition of 
adrenaline and was maximal at the 18 seconds. After 1 minute wash-out of the adrenaline from 
the bath, the inhibition of action potential was reversed. B: Arithmetic means ± SEM (n=16) of 
membrane potential (mV) prior to (white bar) and after exposure of the cells to adrenaline (1 µM; 
black bar). *** indicates very significant difference between control and  addition of adrenaline 
(P<0.001; two-tailed paired t-test). C1: Original tracings of perforated whole-cell recording of 
membrane current prior to (C1 left measurement) and after addition of adrenaline (1 µM; C1 
right measurement). C2: I-V relations of mean current prior to (open triangles) and after exposure 
of mouse islet cells to adrenaline (1 µM; closed squares). D: Arithmetic means ± SEM (n=5) of 
peak current density (pA/pF) prior to (white bar) and after exposure of the cells to adrenaline (1 
µM; black bar). ** indicates significant difference between control and addition of adrenaline 
(P<0.01; two-tailed paired t-test).  E: Original recording of a islet cell. Application of LY 294002 
(10 µM) had no effect on membrane potential. Application of adrenaline (1 µM) in the presence 
of  LY 294002 failed to hyperpolarize mouse islet cells. F: Arithmetic means ± SEM (n=7) of 
membrane potential (mV) prior to (white bar) and after exposure of the cells to adrenaline (1 µM; 
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black bar). There is no significant difference between application of LY and adrenaline combined 
with LY. LY 294002 prevented the adrenaline-induced hyperpolarization in mouse islet cells. G: 
Original recording of a islet cell. Application of Wortmannin (100 nM) had no effect on 
membrane potential (n=7). Application of adrenaline (1 µM) in the presence of  Wortmannin 
(100 nM) failed to hyperpolarize mouse islet cells. H: Arithmetic means ± SEM (n=7) of 
membrane potential (mV) prior to (white bar) and in the presence of the cells to adrenaline (1 
µM; black bar). There is no significant difference between application of Wortmannin (100 nM) 
and adrenaline in the presence of  Wortmannin (P=0.08). Wortmannin (100 nM) prevented the 
adrenaline-induced hyperpolarization of mouse islet cells. I: Original tracings of cell membrane 
potential following an increase of extracellular glucose concentration to 16.8 mM and subsequent 
addition of 1 µM epinephrine in islet cells from PDK1 wild type littermates (pdk1wt).  J: Mean 
cell membrane potential (± SEM, n=5) at 16.8 mM glucose concentration in the absence (white 
bars) and presence (black bars) of 1 µM epinephrine in islet cells from PDK1 wild type 
littermates (pdk1wt). * indicates significant difference from respective value in the absence and 
presence of epinephrine (paired T-Test. P ≤ 0.05). K: Original tracings of cell membrane 
potential following an increase of extracellular glucose concentration to 16.8 mM and subsequent 
addition of 1 µM epinephrine in islet cells from PDK1 hypomorphic mice (pdk1hm). L: Mean cell 
membrane potential (± SEM, n=7) at 16.8 mM glucose concentration in the absence (white bars) 
and presence (black bars) of 1 µM epinephrine in islet cells from PDK1 hypomorphic mice 
(pdk1hm). 
 
 
4.3    Effects of amyloid and ceramide on apoptosis and activity of KV channel in mouse 
pancreatic beta cells 
 
        Amyloid peptides have been known to interfere with cell survival. As in some cells 
apoptotic death is paralleled by ceramide dependent alterations of plasma membrane ion channel 
activity. The present study elucidated the effects of amyloid on ceramide formation and ion 
channel activity in mouse islets. 
 
4.3.1    Effect of amyloid beta fragment Aß1-42 and C2-ceramide on apoptosis of islet cells 
 
 61 
        Isolated islet cells treated with amyloid beta fragment Aß1-42 for 3 hours underwent 
apoptotic cell death (Fig.20A and B). The effect of amyloid was significant at a concentration of 
0.1 µM in the absence of serum whereas under standard culture conditions in the presence of 
serum higher concentrations of amyloid (2 µM) were required for a statistically significant effect 
(Fig. 20C). When C2-ceramide at concentrations higher than 40 µM was added into standard 
culture medium 90 % of the cells died within 2 d. However, lower concentrations of C2-ceramide 
(20 µM) were without any significant effect (Fig .20A, D).  
        These observations show that ceramide and amyloid induce cell death of isulin-secreting 
cells. 
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Fig. 20: Effect of amyloid beta fragment Aß1-42 and C2-ceramide on apoptosis of pancreatic 
beta cells. A. Representative images illustrating fluorescent DAPI+TUNEL staining of 
pancreatic beta cells incubated for 0.1 µM for 3 h, 2 µM for 24h , 2 µM for 48 h with (middle 3 
panels) or without (upper 3 panels) amyloid peptide Aß1-42 , or for 48 h with (lower right 3 
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panels) or without (lower left panel) C2-ceramide (20-60 µM). White arrows and green stained 
cells indicate TUNEL positive cells which suggest apoptotic cells. All nuclei were stained blue 
by DAPI. B. Arithmetic means ± SEM (n = 4) of fractionated nuclei in pancreatic beta cells 
incubated for 3 h with (black bar) or without (open bar) 0.1 µM amyloid peptide Aß1-42. * 
indicates significant difference (P< 0.05; two-tailed unpaired t-test). C. Arithmetic means ± SEM 
(n = 4) of fractionated nuclei in pancreatic beta cells exposed 24 h (left bars) or 48 h (right bars) 
with (black bar) or without (open bar) 2 µM amyloid peptide Aß1-42  (ANOVA, P< 0.01) . D. 
Arithmetic means ± SEM (n = 4) of fractionated nuclei in pancreatic beta cells incubated for 24 h 
(left bars) or 48 h (right bars) in the absence (control, white bars) or in the presence of different 
concentrations of C2-ceramide (20 µM dotted bar, 40 µM hatched bar and 60 µM black bar). ** 
indicates significant difference from control (ANOVA, P< 0.01). 
 
 
 
4.3.2    Effect of amyloid beta fragment Aß1-42  on ceramide formation in pancreatic beta 
cells 
 
        To further analyse whether amyloid peptide Aß1-42 stimulates ceramide production in 
isolated islet cells, the formation of ceramide was visualized by immunofluorescent labelling with 
specific ceramide antibodies. In control cells ceramide was visualized mainly at the periphery of 
the cells (Fig. 21). Treatment of cells with 0.1 µM amyloid for 30 min yielded a marked increase 
of cellular ceramide staining again with stronger staining at the cell periphery. These observation 
suggest that amyloid peptide Aß1-42 may induce apoptotic cell death through the formation of 
ceramide.  
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Fig. 21: Effect of amyloid beta fragment Aß1-42  on ceramide formation in pancreatic beta 
cells. Fluorescence microphotograph of ceramide abundance in pancreatic beta cells prior to (left 
panel) and 30 min following (right panel) treatment with amyloid peptide Aß1-42 (0.1 µM). 
 
 
4.3.3    Effect of amyloid beta fragment Aß1-42 on apoptosis in ASM-KO mouse pancreatic 
islet cells.  
 
       Ceramide formation underneath the plasma membrane may be a result of the activation of 
acid sphingomyelinase (ASM) that cleaves membrane sphingomyeline. To examine whether 
activation of ASM is involved in amyloid-induced apoptotic cell death, the effect of amyloid was 
examined in an islet cell preparation isolated from ASM knockout mice. Even high 
concentrations of amyloid were unable to increase apoptotic cell death over the basal rate of 7 % 
in ASM-KO islet cells (Fig. 22). These observations strongly suggest that amyloid induces 
apoptotic cell death via activation of ASM amd subsequent increase of ceramide production.  
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Fig. 22: Effect of amyloid beta fragment Aß1-42 on apoptosis in ASM-KO mouse pancreatic 
islet cells. A: Representative images illustrating fluorescent DAPI+TUNEL staining of ASM-KO 
mouse pancreatic islet cells without treatment (left panel) and 24 h after (right panel) treatment 
with 1 µM amyloid (white arrows denote TUNEL positive cells). B: Arithmetic means ± SEM (n 
= 4) of fractionated nuclei in wild type mice pancreatic beta cells incubated for 24 hours with 
(black bar) or without (open bar) 1 µM amyloid peptide Aß1-42.** indicates significant difference 
(P< 0.01; two-tailed unpaired t-test). C: Arithmetic means ± SEM (n = 4) of fractionated nuclei in 
ASM-KO mice pancreatic beta cells incubated for 24 hours with (black bar) or without (open bar) 
1 µM amyloid peptide Aß1-42. 
 
 
0
5
10
15
20
25
30
0
5
10
15
20
25
30 **
ASM KO
Control
Con.   1 µM AmyloidT
u
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
ASM-KOCWT
Con.   1 µM AmyloidT
u
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
B
A ASM KO
1 µM Amyloid
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
Tu
n
el
po
sit
iv
e 
ce
lls
(%
)
 66 
4.3.4    Effect of islet amyloid polypeptide (IAPP, 5 µM) 
 
on Kv channel current in WT islet 
cells 
 
        
         As apoptotic cell death is accompanied by changes in ion channel activity, the effect of 
amyloid on whole cell ion current was examined. The administration of islet amyloid polypeptide 
(IAPP, 5 µM) led to a significant decrease of the whole cell outward current within 15 min from 
128.80 ± 9.84 to 87.28 ± 10.30 (pA/pF, n = 6, P< 0.001) and within 25 min the outward current 
was reduced to 78.08 ± 10.03 (n = 6, P< 0.001) (Fig. 23). 
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Fig. 23:  Effect of IAPP 
 
on Kv channel activity in WT mouse islet cells. A: Original tracings 
of voltage gated K+ currents prior to, 15 min and 25 min after addition of solvent solution (left 
measurement) and IAPP
 
(right measurement, 5 µM). Whole cell currents were induced by 200 ms 
voltage pulses increasing by 20 mV steps from –100 mV to +80 mV. B: I-V relations of mean 
peak current amplitude normalized to the cell capacitance (mean peak current density, ± SEM, n 
= 6) prior to (white diamonds), 15 min (white squares) and 25 min (black triangles) after 
exposure of mouse islet cells to solvent solution without (left measurement) and with (right 
measurement) 5 µM IAPP. C: Arithmetic means ± SEM (n = 6) of current density at +100 mV 
prior to (white bars) and following 15 min (hatched bars) and 25 min (black bars) exposure of the 
cells to solvent (left measurement) or to  IAPP (5 µM) (right measurement). *** indicates very 
significant difference from respective value prior to addition of IAPP (P< 0.001; ANOVA). 
 
 
4.3.5    Effect of C2–ceramide  on Kv channel activity in WT mouse islet cells 
 
        The effect of amyloid peptides (IAPP and amyloid) on whole cell Kv channel current was 
mimicked by N-acetyl-D-sphingosine (C2-ceramide, 20 µM) whereas the inactive dihydro-C2-
ceramide (Di-C2, 20 µM) did not significantly modify whole cell outward currents (Fig.24). Di-
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C2 failed to reduce Kv channel current after 15 min. and 25 min. (0 min.: 113.33 ± 16.89 pA/pF; 
15 min.: 116.20 ± 9.61 pA/pF; 25 min.: 114.17 ± 6.27 pA/pF, n = 5, P> 0.05). Application of N-
acetyl-D-sphingosine induces the similar effect as IAPP on Kv channel current in WT islet cells 
(0 min.: 118.33 ± 9.97 pA/pF; 15 min.: 90.92 ± 8.61 pA/pF; 25 min.: 82.61 ± 10.49 pA/pF, n = 6, 
P< 0.001). 
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Fig. 24: Effect of C2–ceramide  on Kv channel activity in pancreatic beta cells. A: Original 
tracings of voltage gated K+ currents prior to, 15 min and 25 min after addition of Di-C2 (left 
measurement, 20 µM) and C2-ceramide (right measurement, 20 µM). B: I-V relations of mean 
peak current density (± SEM, n = 6 each) prior to (white diamonds), 15 min (white squares) and 
25 min (black triangles) exposure to Di-C2 (left panel) and 20 µM C2-ceramide (right panel). C: 
Arithmetic means ± SEM (n = 6) of current density at +100 mV prior to (white bars) and 
following 15 min (hatched bars) and 25 min (black bars) exposure of the cells in the presence of  
20 µM Di-C2 (left panel) and C2-ceramide (right panel). *** indicates very significant difference 
to 0 min. (P< 0.001; ANOVA). 
 
4.3.6    C2 but not IAPP inhibited Kv channel current in ASM-KO islet cells  
  
 
As amyloid and ceramide both induce comparable inhibition of Kv channel activities in 
islet cells, experiments were performed to analyse whether amyloid affects Kv channel activity 
through ceramide formation. Indeed the application of IAPP to ASM-KO islet cells did not 
induce any change on Kv channel current (n=6, P> 0.05). In contrast, The administration of C2-
ceramide significantly reduced channel current within 15 min from 119.75 ± 13.29 to 84.49 ± 
8.98 (pA/pF, n = 5, P< 0.05) and within 25 min reduced to 62.31 ± 11.92 (n = 5, P< 0.05) (Fig. 
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25).  These observations suggest the hypothesis that amyloid through the stimulation of ASM and 
ceramide formation affects ion channel activity in insulin secreting cells. 
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Fig. 25:  Effect of IAPP 
 
on Kv channel activity in ASM-KO mouse islet cells was abolished. 
A: Original tracings of voltage gated K+ currents prior to, 15 min and 25 min after addition of 
solvent solution (left measurement), C2 20 µM (middle measurement) and IAPP 5 µM (right 
measurement). Whole cell currents were induced by 200 ms voltage pulses increasing by 20 mV 
steps from –100 mV to +80 mV. B: I-V relations of mean peak current amplitude normalized to 
the cell capacitance (mean peak current density, ± SEM, n = 6) prior to (white diamonds), 15 min 
(white squares) and 25 min (black triangles) after exposure of mouse islet cells to solvent solution 
(left measurement), C2 (middle measurement, 20 µM) and IAPP (right measurement, 5 µM). C: 
Arithmetic means ± SEM (n = 6) of peak current density at +100 mV prior to (white bars) and 
following 15 min (hatched bars) and 25 min (black bars) exposure of the cells to solvent solution 
(left measurement), C2 (middle measurement, 20 µM) and IAPP (right measurement, 5 µM). * 
indicates significant difference from respective value prior to addition of C2 (P< 0.05; ANOVA). 
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5    DISCUSSION 
 
 
 
        The Regulation of membrane ion channel activities plays a crucial role in biological 
functions in insulin secreting cells. The overwhelming major function of ion channels is the 
regulation of insulin secretion. But they also influence survival and apoptosis of insulin secreting 
cells. Insulin is a critically important regulator of whole body energy metabolism. When insulin 
secretion is absent or reduced, or when peripheral tissues fail to respond to insulin, it results in 
hyperglycaemia leading ultimately to diabetes. For the understanding of the physiological 
regulation of insulin secretion and the pathophysiological dysfunction of beta cells the 
measurement of electrical activity of beta cells and the underlying changes in ion currents was 
crucial and was made possible due to the introduction of the patch-clamp technique ( Hamill et 
al.1981). 
        Channel regulators can be roughly divided into two groups: the activators and the inhibitors. 
Inhibitors of the KATP , KV  channels close these K+ channels an effect that depolarizes beta cells 
stimulate insulin release (Ashcroft et al.1988a; Ashcroft et al.1988b; Rorsman et al. 1990; Chen 
et al.2007; MacDonald et al.2003b). Physiological inhibitors include nutrients which are 
metabolized by the beta cell and which generate ATP such as glucose and certain 
pharmacological agents such as sulfonylureas. Activators of K+ channels reduce electrical 
activity of beta cells, induce a hyperpolarization and inhibit insulin release. A number of 
substances, especially hormones and neurotransmitters that act through Gi coupeled receptors, 
and pharmacological agents such as diazoxide inhibit electrical activity and insulin secretion. But 
the way in which they affect channel activities is still not complete clear. The present study 
explored whether the PI3kinase signalling pathways affects electrical activity of beta cells and 
whether beta cell ion currents are influenced by substances that affect beta cell survival.  
 
 
5.1   The Regulation of membrane potential by glucose and tolbutamide 
 
        The basic functions and physiology of the beta cells are relatively well understood.  The 
primary function of the beta cell is to correlate the release of insulin with changes in blood 
glucose concentrations. When blood glucose, an essential nutritional stimulator, increases the 
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beta cell is stimulated and starts to be electrical active (Henquin et al.1984). Glucose transport 
protein-2 (GLUT2) and a kinase (glucokinase) act as glucose sensors (Efrat et al.1994; Im et 
al.2006). These proteins have a low affinity for glucose. Both, the transporter and the enzyme, are 
halfmaximally active at around 5-5.5 mM (Efrat et al.1994; Im et al.2006; Kuniaki Takata.1996; 
Watson et al.2001). The presented data show that at a glucose concentration below 5 mM,, beta 
cells are electrically silent with a resting membrane potential of about - 70 mV. Raising the 
external glucose concentration to 5.6 mM, due to the low Km of Glut-2 and of glucokinase, 
uptake and metabolism is increased. At the same time, membrane potential is elevated to – 60 
mV. but no action potentials were generated. Only at glucose concentrations higher than 7 mM, 
depolarization becomes sufficient to reach the threshold potential ( ~ - 50 mV) at which electrical 
activity is initiated and insulin release is stimulated. At higher glucose concentrations 11.2 mM 
and 16.8 mM the membrane depolarized further and reached the same plateau level (-38.50 ± 
1.53 and -38.82 ± 1.07 mV, n= 26 and 38; respectively). Isolated beta cells were continuously 
active and generated action potentials at glucose concentrations higher that 7 mM. This behaviour 
is specific for isolated beta cells. Beta cells that remain in the islet and in contact with other islet 
cells show oscillatory membrane activity at intermediate glucose concentrations. The respone to 
glucose is slow since the closure of KATP channels and the depolarisation depends on metabolism 
and the generation of ATP. Action potentials were generated when glucose was increased from 
2.8 mM to 11.2 or 16.8 mM glucose after 66.92 ± 7.37 s and 62.63 ± 6.93 s, respectively. 
Furthermore, 78.05 % of cells measured responsed to high glucose with the generation of action 
potentials. This rate is in accordance with the percentage of endocrine cells within the islets 
immunocytochemically stained for insulin (Elayat et al.1995). These data suggest that mouse beta 
cells remain responsive to glucose after isolation and cell culture and the glucose repsponsiveness 
may be used to distinguish beta cells from non beta cells.  
 Sulphonylureas are a class of anti-diabetic drugs that have been used for  T2DM over half 
of the century. These drugs act as potent and direct blockers of KATP channel activity by binding 
to the SUR1 subunit of the KATP channel. They stimulate insulin release (Boyd. 1988; de Weille 
et al. 1989; Ashford. 1990). Tolbutamide is the classic example of the first generation of 
sulphonylureas that consists solely of the sulphonylurea group (Ashford. 1990). The time course 
for the inhibition of channel activity by tolbutamide is rapid as confirmed in this study. The 
initiation of action potential is accomplished after 3.6 ± 0.2 s and in 1-2 s the maximal effect was 
reached. This time course reflects the direct binding of tolbutamide to KATP channels in contrast 
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to the slow effect of glucose on membrane potential. The data further show that the inhibition of 
KATP current by tolbutamide is reversible. The membrane potential recovered after wash-out of 
tolbutamide in almost all the measurement (85 out of 93) within 1 min. This may reflect a quick 
dissociation of the drug-receptor complex. Electrophysiological studies have demonstrated that 
tolbutamide is specific for KATP channel as the drug has no significant effect on the Kv current, 
Ca2 + currents, Ca2+activated K+ channels and non-selective cation channels (Rorsman and Trube. 
1986; Trube et al. 1986; Sturgess et al. 1988; Ashcroft et al. 1989a;Gillis et al. 1989). 
Tolbutamide is therefore a widely used tool to study the role of K+ channels in insulin secreting 
cells. In the following experiments tolbutamide was used to block the prominent KATP currents 
that allowed the examination of GIRK and Kv channels in isolated mouse beta cells.  
 
 
5.2    Regulation of membrane potential and membrane currents by leptin, IGF-1, insulin 
and adrenaline 
 
 
 Leptin, the obesity (ob) gene product, is produced in adipose tissue and regulates the 
feeding behaviour and energy metabolism. Exogenous leptin has been shown to inhibit glucose-
induced insulin secretion of islets isolated from ob/ob and wild-type mice (Emilsson et al. 1997; 
Keiffer et al. 1997). Electrophysiologiocal studies indicate that in isolated arcuate neurones 
(Mirshamsi et al. 2004) and in an insulin-secreting cell line CRI-G1 (Harvey et al. 1997), leptin 
activates KATP channels and induces a hyperpolarization of insulin secreting cells. The present 
experiments are in accordance with these findings that leptin activates KATP channels that leads to 
a hyperpolarization of pancreatic beta cells and may account for the inhibition of insulin 
secretion. It has been shown in a haematopoietic cell line that the activation of leptin receptors 
stimulates janus kinase 2 (JAK2) (Ghilardi& Skoda. 1997). Whether in beta cells the activation 
of this pathway by leptin underlies its inhibitory effect on secretion is unkown (Ihle.1995). To 
examine whether the PI3 kinase signalling pathway is involved in leptin mediate effects on 
membrane potential changes of beta cells LY294002, selective inhibitors of PI 3-kinase (Vlahos 
et al.1994), was applied. The results demonstrate that LY294002 occluded leptin-induced 
hyperpolarisation of mouse islet cells and suggest that the effects of leptin on membrane potential 
involves the activation of IGF-1/insulin/IRS/PI3 kinase signalling (Myers & White, 1996). A 
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similar observation was made in isolated arcuate neurones, where leptin increased the activity of 
KATP channels in a PI3 kinase dependent manner (Mirshamsi et al. 2004). Furthermore this study 
using primary mouse islet cells confirms a similar observation made with an the insulin secreting 
cell line CRI-G1 cells (Harvey et al.1998). An important lipid that regulates KATP channel 
opening is PIP2 . Treatment of cells with PI3 kinase inhibitors results in the depletion of PIP2 . 
The reason for the inhibition of the hyperpolarisation of islet cells by leptin may thus be the 
depletion of PIP2. Whether leptin stimulates PIP2 formation, that leads to the opening of KATP 
channels, or whether the effect of leptin is mediated through the induction of actin filament 
depolymerization as suggested by Mirshamsi et al. needs further analysis (Mirshamsi et al 2004).  
 Human insulin-like growth factor-I (IGF-1) influences cell growth and cell differentiation 
and also exerts insulin-like effects on glucose homeostasis. IGF-I infusion in vivo decreased 
plasma levels of lactate (Jacob et al.1989; Jacob et al.1992), amino acids (Jacob et al.1989; Jacob, 
et al.1992) and glucose (Jacob et al.1989; Zapf et al. 1986). in healthy rats exposed to 
hyperglycemia. IGF-I infusion dose-dependently reduced plasma insulin and net glucose uptake 
(Fürnsinn et al.1994). The results demonstrate that IGF-1 is a potent inhibitor of insulin release. 
The hyperpolarizing effect of IGF-1 on membrane potential shown here may explain the 
inhibition insulin release induced by IGF-1. The underlying mechanism involves the activation of 
PI3 kinase as LY29402 inhibited IGF-1 induced hyperpolarisation. Interestingly, mice lacking 
IGF-1 receptors in beta cells display increased basal (fed and fasted) insulin levels, but defective 
glucose-stimulated insulin secretion (Kulkarni et al.2002; Xuan et al.2002). These results suggest 
that IGF-1 receptor signalling that favors beta cell hyperpolarisation might be important for the 
regulation of basal insulin secretion. 
As insulin and IGF-1 activate the same signal transduction pathways, insulin may exert 
similar effects on beta cell membrane potential as does IGF-1. However the study here shows no 
significant effect of exogenous insulin on membrane potential in mouse islet cells. This finding 
confirms a reported study that application of insulin (0.1—1000 nM) had no effect on the resting 
membrane potential of insulin secreting cells (Harvey et al.1998). Recent data has been shown in 
mouse islet cells that a 20 min pretreatment with insulin exerted a marked reduction in the 
sensitivity of beta cell KATP channels to ATP (Leung et al.2006). This results in a significantly 
larger outward current in the presence of 1 mM ATP in the pipette solution in cell treated with 
insulin when compared to untreated cells (Leung et al.2006). Insulin has been postulated to exert 
a negative-feedback control on its own secretion (Koranyi et al.1992; Marchetti et al.1995). 
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However, a acute effect of insulin on KATP channels through the activation of PI3 kinase seems 
not to be involved.  
 It is well-known adrenaline acts as antagonist of insulin in that the catecholamine inhibits 
insulin secretion and enhances blood glucose levels. Adrenline induces a hyperpolarization of 
insulin secreting cells via a pertussis toxin (PTX)-sensitive mechanism (Abel et al.1996). The 
effect is mediated through the activation of alpha(2A)- and alpha(2C)-adrenoceptors and the 
respective intracellular signaling pathways, resulting in an inhibition of adenylylcyclase and a 
hyperpolarisation (Peterhoff et al.2003). Adrenaline did not influence basal or insulin-stimulated 
PI 3 kinase activity in rat fast-twitch epitrochlearis muscle (Jensen et al.2008). In contrast 
activation of alpha1 adrenergic receptors by noradrenaline has been shown to stimulate PI 3-
kinase and to increase mitogenesis in human vascular smooth muscle cells (Hu et al.1996). This 
study analysed whether in insulin secreting cells adrenalin exerts effects dependent on PI-3 
kinase signalling pathway. The experiments of this study demonstrate that 1µM adrenaline 
induced a significant hyperpolarization and activated outward currents in mouse beta cells. 
Furthermore, the effect of adrenaline was inhibited by both PI 3-kinase inhibitors, LY294002 and 
wortmannin. These observations suggest that in mouse islet cells, adrenaline inhibits insulin 
secretion through PI 3-kinase signalling pathway. Adrenaline induced a significant faster 
hyperpolarisation than leptin or IGF-1. For the understanding of the mechanism of activation by 
adrenaline further studies are needed. Indeed it is not known whether and by which mechanism 
adrenaline affects PIP2. 
In conclusion, leptin, IGF-1 and adrenaline induce a hyperpolarization of mouse pancreatic 
beta cells via a mechanism that involves PI 3-kinase signaling pathway. Exogenous insulin failed to 
elicit a significant effect on cell membrane potential in mouse beta cells. 
 
 
5.3    Regulation of amyloid and ceramide on apoptosis and KV channel activity 
 
 
 Cell death can follow two distinct pathways: apoptosis or necrosis. Morphologically, 
necrosis is characterized by a dramatic swelling in cell size and rupture of the plasma membrane, 
with release of the cellular contents into the extracellular space (Gores et al.1990). This 
consequently results in a damage of neighboring tissues and triggers the production of  cytokines 
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(Haslett.1992). This process has been proved to be a relatively passive process associated with 
rapid cellular ATP depletion. Unlike necrosis, apoptosis is characterized by cell shrinkage, 
chromatin condensation, internucleosomal DNA fragmentation and without influence of 
cytokines (Kerr et al.1965; McConkey et al.1998). Apoptosis describes a active form of cell death 
and constitutes a mechanism of cell replacement and clearance of damaged cells during several 
physiological and pathological situations (DeLong. 1998).  
 In T2DM, the islet typically contains extracellular deposits of amyloid derived from IAPP 
(Maloy et al.1981; Clark et al.1987; Cooper  et al.1987; Johnson et al.1989). Islet amyloid has 
also been reported in transplanted human islets (Westermark et al.1995; Westermark et al.2005). 
Thus, amyloid (specially indicates IAPP) deposition became a pathological feature in T2DM that 
may affect beta cell mass as a result from increased beta cell death. 
 It has been reported that the amount of islet amyloid rather than the formation islet 
amyloid deposits is related to increased apoptosis of beta cells in a murine model of T2DM 
(Butler et al.2003). It is suggested that soluble IAPP oligomers but not islet amyloid are 
responsible for increased beta cell apoptosis in mice and humans .. On the other hand, other 
studies showed that amyloid precursor peptides, such as the Aß1-42 fragment, triggered suicidal 
death in a variety of cells including neurons (Abdul et al.2006; Huang and May. 2006; Malaplate-
Armand et al.2006; Ran et al.2006; Raynaud and Marcilhac.2006; Yu et al.2006), endothelial 
cells (Donnini et al.2006), neutrophils (Park et al.2006), erythrocytes (Nicolay et al.2007). This 
soluble amyloid Aß1-42 peptide was used to examine whether soluble amyloid can induce apoptosis 
in mouse beta cell. The present study reveals that Aß1-42 indeed triggers the suicidal death of 
pancreatic beta cells. This effect of Aß1-42 is obviously secondary to stimulation of acid 
sphiungomyelinase and subsequent formation of ceramide. Accordingly, the effect is mimicked by 
addition of ceramide. More importantly, genetic knockout of acid sphingomyelinase abrogates the 
proapoptotic effect of Aß1-42. Ceramide has been shown to participate in the triggering of cell 
death in a variety of cells including T-lymphocytes (Gulbins et al.1997), hepatocytes (Lang et 
al.2007), erythrocytes (Bentzen et al., 2007; Lang et al., 2006; Nicolay et al., 2006) and 
pancreatic beta cells (Newsholme et al., 2007). 
 Recent experiment provides further evidence about the mechanism of apoptotic cell death 
induced by amyloid. It is shown, that h-IAPP oligomers may act through the interaction with the 
cell membrane that disturbs cell-to-cell integrity and disrupts the morphology of human islets. 
These actions of h-IAPP not only induces apoptotic cell death but severely impairs  glucose-
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mediated insulin secretion (Ritzel et al.2007). Apart from morphological changes, apoptotic 
pathways induced by amyloids include the ER stress pathway (Haataja et al.2008; Huang et 
al.2007). Amyloid peptides may be effective through stimulation of Ca2+ entry (Park et al.2006), 
calpain activation (Raynaud and Marcilhac.2006), oxidative stress (Abdul et al.2006; Huang and 
May. 2006; Ran et al.2006) and ceramide formation (Malaplate-Armand et al.2006). 
 Here, it is shown that amyloid inhibited Kv channel activity in pancreatic beta cells. 
Amyloid was again effective through stimulation of ceramide formation. Ceramide has been 
shown to modify the activity of a variety of ion channels including K+ channels (Bai et al., 2007; 
Bock et al., 2003; Chapman et al., 2005; Gulbins et al., 1997; Hida et al., 1998; Ramstrom et al., 
2004; Wu et al., 2001; Zhang et al., 2002), Ca2+ channels (Chik et al., 2004; Lepple-Wienhues et 
al., 1999) and Na+ channels (Liu et al., 2007). In some cells inhibition of Kv channels has been 
shown to compromise cell proliferation (Patel and Lazdunski.2004; Wang.2004) and facilitate 
apoptosis (Bankers-Fulbright et al., 1998; Chin et al., 1997; Han et al., 2004; Miki et al., 1997; 
Pal et al., 2004; Patel and Lazdunski 2004). On the other hand, amyloid (Colom et al., 1998; Yu 
et al., 1998) and ceramide (Yu et al., 1999) induced apoptotic cell death may be paralleled by 
activation of K+ channels. Activation of K+ channels leads to cell shrinkage, a hallmark of 
suicidal cell death (Bortner et al., 1997; Bortner and Cidlowski 1999; Bortner and Cidlowski 
2004; Maeno et al., 2000; Schneider et al., 2007). This study, however, supports the hypothesis 
that ceramide does not stimulate but inhibits Kv currents. That Kv channel activity is changed 
during apoptosis has been shown in Jurkat T lymphocytes, where CD95-induced apoptosis is 
paralleled by inhibition of Kv1.3 channels (Szabo et al. 1996; Szabo et al. 2004). This channel is 
the cell volume regulatory K+ channel of Jurkat cells (Deutsch and Chen. 1993). CD95-triggering 
leads to tyrosine phosphorylation of the Kv1.3 channel protein (Gulbins et al.1997; Szabo et 
al.1996). Accordingly, CD95 induced inhibition of Kv1.3 requires the activation of the kinase 
Lck56 (Gulbins et al.1997; Szabo et al.1996). The inhibitory effect of CD95 on Kv1.3 channel 
activity is mimicked by the sphingomyelinase product ceramide, which similarly induces 
apoptosis (Gulbins et al.1997; Gulbins et al.2000).  
 The inhibition of Kv channels in insulijn secreting cells may favour an increased Ca2+ 
load in cells stimulated by hyperglycemia.The notion that a sustained cellular Ca2+ overload is 
highly toxic by causing massive activation of caspases that triggers cell-death signaling pathway 
and the toxicity of Ca2+ ionophores in cultured cells was one of the first mechanisms described 
(Pressman.1976; Fariss et al.1985).  More data, however, have suggested that both at early and 
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late stages of the apoptotic pathway, the increases of [Ca2+]c can been observed (Kruman et al., 
1998; Tombal et al.,1999; Lynch et al., 2000) and both Ca2+ release from the ER and capacitative 
Ca2+ influx through Ca2+ release-activated Ca2+ channels have been proposed to be apoptogenic 
(Pinton and Rizzuto, 2006). Thus, the concept is that severe Ca2+ dysregulation can promote cell 
death and result in apoptosis. The present experiment of patch clamp reveals, IAPP and ceramide 
both within 15-25 min decrease KV channel current in islet cells. The inhibition of Kv channels 
was only partly reversible after wash-out of amyloid and ceramide. These finding support the 
isdea that a sustained closure of Kv channels and activation of Cav channels results in a long 
lasting overload of Ca2. As in ASM-KO islet cells ceramide still induced Kv channel closure and 
apoptosis while the effect of amyloid was reduced it is concluded that amyloid at least in part 
induces apoptosis through ASMase and the formation of ceramide. The mechanism underlying 
amyloid mediated activation of ASM and NSM (neutral sphingomyelinase) has been suggested 
previously.  
 In pancreatic beta cells,  Kv channels may further participate in the regulation of insulin 
release (MacDonald et al., 2002c; Ullrich et al., 2005). Accordingly, inhibition of Kv channels 
augments glucose-induced insulin secretion and increase oxidative stress that may also contribute 
to the induction of apoptotic cell death (MacDonald et al., 2002c). Conversely, glucocorticoids 
stimulate Kv1.5 channels, thus accelerating the repolarisation of the cell membrane upon glucose 
induced depolarization and blunting the Ca2+ entry through voltage gated Ca2+ channels (Ullrich 
et al., 2005). Increased Kv channel activity may account for reduced insulin secretion observed 
under glucocorticoid excess. 
 In conclusion, the study shows for the first time that amyloid as well as ceramide reduce Kv 
channel activity insulin secreting cells. Further evidences suggest that amyloid triggers apoptosis of 
pancreatic beta cells at least in part through the activation of ASM and the formation of ceramide. 
These events may contribute to the pathophysiology of amyloid related diseases such as diabetes 
mellitus and Alzheimer.  
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